PMCID	SENTENCE_NUMBER	SENTENCE	SENTENCE_INDICES	ONTOLOGY_CONCEPT_IDS_LIST
15005800	0	['Late gestational lung hypoplasia in a mouse model of the Smith-Lemli-Opitz syndrome\n\nAbstract\n\nBackground\n\nNormal post-squalene cholesterol biosynthesis is important for mammalian embryonic development.']	(0, 202)	['CHEBI:15440', 'CHEBI:16113', 'GO:0007565', 'GO:0006695', 'GO:0006695', 'GO:0009790', 'GO:0009790', 'NCBITaxon:10088', 'NCBITaxon:40674', 'UBERON:0002048', 'UBERON:0000922']
15005800	1	['Neonatal mice lacking functional dehydrocholesterol Δ7-reductase (Dhcr7), a model for the human disease of Smith-Lemli-Opitz syndrome, die within 24 hours of birth.']	(203, 367)	['GO:0016265', 'GO:0007567', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'NCBITaxon:9606', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PATO_UBERON_EXT:neonate_or_newborn']
15005800	2	['Although they have a number of biochemical and structural abnormalities, one cause of death is from apparent respiratory failure due to developmental pulmonary abnormalities.']	(368, 542)	['CHEBI_EXT:biochemical', 'GO:0016265', 'UBERON:0001004', 'UBERON:0002048']
15005800	3	['Results\n\nIn this study, we characterized further the role of cholesterol deficiency in lung development of these mice.']	(544, 662)	['CHEBI:16113', 'GO:0030324', 'GO:0030324', 'NCBITaxon:10088', 'UBERON:0002048']
15005800	4	['Significant growth retardation, beginning at E14.5~E16.5, was observed in Dhcr7-/- embryos.']	(663, 754)	['GO_EXT:biological_growth_entity_or_process', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922']
15005800	5	['Normal lobation but smaller lungs with a significant decrease in lung-to-body weight ratio was noted in Dhcr7-/- embryos, compared to controls.']	(755, 898)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0002048', 'UBERON_EXT:body', 'UBERON:0000922']
15005800	6	['Lung branching morphogenesis was comparable between Dhcr7-/- and controls at early stages, but delayed saccular development was visible in all Dhcr7-/- embryos from E17.5 onwards.']	(899, 1078)	['GO:0060441', 'GO:0060441', 'GO:0060441', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0000116', 'UBERON:0000922']
15005800	7	['Impaired pre-alveolar development of varying severity, inhibited cell proliferation, delayed differentiation of type I alveolar epithelial cells (AECs) and delayed vascular development were all evident in knockout lungs.']	(1079, 1299)	['CL_GO_EXT:cell', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'GO:0008283', 'GO:0008283', 'GO:0030154', 'GO:0030154', 'GO:0030154', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'UBERON:0003215', 'UBERON:0003215', 'UBERON:0000483', 'UBERON_EXT:vascular_system_or_vasculature_or_vessel', 'UBERON:0002048']
15005800	8	['Differentiation of type II AECs was apparently normal as judged by surfactant protein (SP) mRNAs and SP-C immunostaining.']	(1300, 1421)	['CHEBI_EXT:35195', 'CHEBI_PR_EXT:protein', 'CHEBI_SO_EXT:mRNA', 'CL:0002063', 'CL:0002063', 'CL:0002063', 'GO_RO_EXT:developmental_differentiation_process', 'CHEBI_PR_EXT:protein', 'PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014774', 'CHEBI_SO_EXT:mRNA']
15005800	9	['A significant amount of cholesterol was detectable in knockout lungs, implicating some maternal transfer of cholesterol.']	(1422, 1542)	['CHEBI:16113', 'CHEBI:16113', 'GO:0030301', 'GO:0030301', 'GO:0030301', 'UBERON:0002048']
15005800	10	['No significant differences of the spatial-temporal localization of sonic hedgehog (Shh) or its downstream targets by immunohistochemistry were detected between knockout and wild-type lungs and Shh autoprocessing occurred normally in tissues from Dhcr7-/- embryos.']	(1543, 1806)	['GO_PATO_EXT:biological_localization_process_or_quality', 'GO:0016540', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'PR_EXT:000014841', 'PR_EXT:000014841', 'PR_EXT:000014841', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:sequence_alteration_process', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0000479', 'UBERON:0000922']
15005800	11	['Conclusion\n\nOur data indicated that cholesterol deficiency caused by Dhcr7 null was associated with a distinct lung saccular hypoplasia, characterized by failure to terminally differentiate alveolar sacs, a delayed differentiation of type I AECs and an immature vascular network at late gestational stages.']	(1808, 2114)	['CHEBI:16113', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'GO_RO_EXT:developmental_differentiation_process', 'GO_RO_EXT:developmental_differentiation_process', 'GO:0007565', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:null_sequence_entity', 'UBERON:0000116', 'UBERON:0000116', 'UBERON:0002169', 'UBERON:0002169', 'UBERON:0002049', 'UBERON:0002049']
15005800	12	['The molecular mechanism of impaired lung development associated with sterol deficiency by Dhcr7 loss is still unknown, but these results do not support the involvement of dysregulated Shh-Patched-Gli pathway in causing this defect.']	(2115, 2346)	['CHEBI_EXT:polyatomic_entity_or_group', 'CHEBI:15889', 'GO:0030324', 'GO:0030324', 'GO:0065007', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'PR_EXT:Patched', 'PR_EXT:Gli', 'UBERON:0002048']
15005800	13	['Background\n\nCholesterol is a necessary membrane constituent of all mammalian, reptile and avian cells, as well as a few other organisms, but not all eukaryotic organisms.']	(2348, 2518)	['CHEBI:16113', 'CL_GO_EXT:cell', 'GO:0016020', 'CL_GO_EXT:cell', 'NCBITaxon:40674', 'NCBITaxon_EXT:reptile', 'NCBITaxon:8782', 'NCBITaxon:1', 'NCBITaxon:2759', 'NCBITaxon:2759']
15005800	14	['In the latter cases, such as plants and fungi, cholesterol-like sterols (phytosterols, ergosterol etc.)']	(2519, 2622)	['CHEBI:16113', 'CHEBI:15889', 'CHEBI:26125', 'CHEBI:16933', 'NCBITaxon:3193', 'NCBITaxon:4751']
15005800	15	['seem to substitute for cholesterol.']	(2623, 2658)	['CHEBI:16113']
15005800	16	['The precise need for sterols in biological membranes still remains poorly defined, though its link with microdomains (variously termed rafts, caveoli etc.)']	(2659, 2814)	['CHEBI:15889', 'CHEBI_GO_EXT:biological_process_or_quality_or_role', 'CHEBI_GO_EXT:biological_process_or_quality_or_role', 'GO:0016020', 'GO:0098857', 'GO:0045121', 'GO:0005901']
15005800	17	['may be part of the answer [1].']	(2815, 2845)	[]
15005800	18	["Although the accumulation of cholesterol in atherosclerotic plaques has led to the concept that 'too much' cholesterol may be deleterious, too little cholesterol has now been proven pathophysiological for abnormal embryonic development."]	(2846, 3082)	['CHEBI:16113', 'CHEBI:16113', 'CHEBI:16113', 'GO:0009790', 'GO:0009790', 'UBERON:0000922']
15005800	19	['Smith-Lemli-Opitz syndrome (SLOS, MIM 270400), a relative common dysmorphology disorder, is caused by mutations in DHCR7 [2-5], which encodes for 7-dehydrocholesterol Δ7-reductase and catalyzes a final step of cholesterol biosynthesis.']	(3083, 3318)	['CHEBI:17759', 'CHEBI:17759', 'CHEBI:17759', 'CHEBI:16113', 'GO:0006695', 'GO:0006695', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_MOP_EXT:catalysis', 'GO_MOP_EXT:catalysis', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_alteration_entity_or_process', 'SO_EXT:sequence_coding_function']
15005800	20	['Recognition of other dysmorphology syndromes caused by defects in the post-squalene cholesterol biosynthesis pathway, such as desmosterolosis, lathosterolosis, X-linked chondrodysplasia punctanta and CHILD syndrome [6-15], has strengthened this concept.']	(3319, 3572)	['CHEBI:15440', 'CHEBI:16113', 'GO:0006695', 'GO:0006695', 'GO:0000805']
15005800	21	['Genetic disruption of the Dhcr7 results in neonatal lethality [16].']	(3574, 3641)	['GO_EXT:fatality_or_lethality', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:0000704', 'PATO_UBERON_EXT:neonate_or_newborn']
15005800	22	['Neonatal mice homozygous for the Dhcr7 gene disruption are deficient in cholesterol and have increased accumulation of the cholesterol precursor 7-dehydrocholesterol (7DHC).']	(3642, 3815)	['CHEBI:16113', 'CHEBI:16113', 'CHEBI:17759', 'CHEBI:17759', 'CHEBI:17759', 'CHEBI:17759', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:0000704', 'PATO_UBERON_EXT:neonate_or_newborn']
15005800	23	['Although no embryonic lethality was noted, these knockout pups exhibited a number of developmental abnormalities and died within 24 h after birth.']	(3816, 3962)	['GO_EXT:fatality_or_lethality', 'GO:0016265', 'GO:0007567', 'NCBITaxon_UBERON_EXT:pup', 'UBERON:0000922', 'NCBITaxon_UBERON_EXT:pup']
15005800	24	['A similar mouse SLOS model, generated by replacing exons 3, 4 and part of exon 5 of the murine Dhcr7 gene, with similar biochemical and structural defects and a 100 % neonatal lethality, has also been reported [17].']	(3963, 4178)	['CHEBI_EXT:biochemical', 'GO_EXT:fatality_or_lethality', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'NCBITaxon:39107', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_substitution_process', 'SO_EXT:0000147', 'SO_EXT:0000852', 'SO_EXT:0000852', 'SO_EXT:0000852', 'SO_EXT:0000704', 'PATO_UBERON_EXT:neonate_or_newborn']
15005800	25	['Poor lung development or diffuse lung alveolar atelectasis with cyanotic and lethargic breathing are consistent between both Dhcr7 null models [16,17], and therefore is the likely reason for the respiratory insufficiency and subsequent death of Dhcr7-/- pups.']	(4179, 4438)	['GO:0030324', 'GO:0030324', 'GO:0016265', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon_UBERON_EXT:pup', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0002299', 'UBERON:0002299', 'UBERON:0001004', 'NCBITaxon_UBERON_EXT:pup']
15005800	26	['These Dhcr7 knockout mice are models for human SLOS, especially the more severely affected patients, since early postnatal lethality with respiratory failure has been reported in severe SLOS cases [4,5].']	(4439, 4642)	['GO:0007567', 'GO_EXT:fatality_or_lethality', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'NCBITaxon:9606', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'UBERON:0001004']
15005800	27	['Developmental lung abnormalities are also relatively common in SLOS patients, including pulmonary hypoplasia, abnormal pulmonary lobation and pulmonary arteries, anomalies of laryngeal and tracheal development [18].']	(4643, 4858)	['GO:0060438', 'GO:0060438', 'UBERON:0002048', 'UBERON:0002048', 'UBERON:0002048', 'UBERON:0002012', 'UBERON:0002012', 'UBERON:0001737', 'UBERON:0003126']
15005800	28	['Mammalian lung is unique in that it is fully developed, but does not function for gas exchange until at the moment of birth; the majority of structural development and maturation takes place in utero.']	(4860, 5060)	['GO:0007585', 'GO:0007585', 'GO:0007567', 'GO_PATO_EXT:biological_maturation', 'NCBITaxon:40674', 'UBERON:0002048']
15005800	29	['Lung development is a complex process that involves branching morphogenesis of epithelium, interstitial development including vasculogenesis, cellular differentiation, biochemical maturation and physical growth.']	(5061, 5272)	['CHEBI_EXT:biochemical', 'CL_GO_EXT:cell', 'GO:0030324', 'GO:0030324', 'GO:0061138', 'GO:0061138', 'GO:0061138', 'GO:0061138', 'GO:0001570', 'GO:0030154', 'GO:0030154', 'GO_PATO_EXT:biological_maturation', 'GO_EXT:biological_growth_entity_or_process', 'CL_GO_EXT:cell', 'UBERON:0002048', 'UBERON:0000483', 'UBERON:0005169']
15005800	30	['Four stages of mouse lung development have been described, based upon the histological appearances of lung; pseudoglandular, canalicular, terminal saccular and alveolar stages [19].']	(5273, 5454)	['GO:0030324', 'GO:0030324', 'NCBITaxon:10088', 'UBERON:0002048', 'UBERON:0002048', 'UBERON:0000116', 'UBERON:0003215']
15005800	31	['Impaired hedgehog function has been proposed as a mechanism underlying malformations found in SLOS.']	(5456, 5555)	['PR_EXT:hedgehog']
15005800	32	['Hedgehog family members play diverse roles in embryonic development, and cholesterol is necessary for maturation of these morphogens [20-23].']	(5556, 5697)	['CHEBI:16113', 'GO:0009790', 'GO:0009790', 'GO_PATO_EXT:biological_maturation', 'GO_EXT:0016015', 'PR_EXT:hedgehog', 'UBERON:0000922']
15005800	33	['The sonic hedgehog (Shh) signaling cascade has been shown to play a central role in lung development [24-26].']	(5698, 5807)	['GO:0007224', 'GO:0007224', 'GO:0007224', 'GO:0030324', 'GO:0030324', 'PR_EXT:000014841', 'PR_EXT:000014841', 'PR_EXT:000014841', 'UBERON:0002048']
15005800	34	['Loss of Shh function resulted in severe lung defects associated with loss of branching morphogenesis, but preserved proximal-to-distal differentiation of lung epithelium [24].']	(5808, 5983)	['GO:0001763', 'GO:0001763', 'GO_RO_EXT:developmental_differentiation_process', 'PR_EXT:000014841', 'UBERON:0002048', 'UBERON:0000115', 'UBERON:0000115']
15005800	35	['Overexpression of Shh in the distal lung epithelium resulted in the absence of functional alveoli and an increase in interstitial tissue caused by an increased proliferation of both epithelial and mesenchyme cells [26].']	(5984, 6203)	['CL:0000066', 'CL:0000134', 'CL:0000134', 'CL:0000066', 'GO:0010467', 'GO:0050673', 'GO:0010463', 'GO:0050673', 'GO:0010463', 'GO:0050673', 'GO:0010463', 'GO:0050673', 'GO:0010463', 'CL_GO_EXT:cell', 'PR_EXT:000014841', 'UBERON:0000115', 'UBERON:0000115', 'UBERON:0003215', 'UBERON:0005169', 'UBERON:0005169', 'UBERON:0000483', 'UBERON:0003104']
15005800	36	['Mice with Shh overexpression died less than 24 h after birth, probably owing to respiratory failure.']	(6204, 6304)	['GO:0010467', 'GO:0016265', 'GO:0007567', 'NCBITaxon:10088', 'PR_EXT:000014841', 'UBERON:0001004']
15005800	37	['It has been reported that inhibition of cholesterol biosynthesis by chemical inhibitors of Dhcr7 also led to a disturbance of the Shh signaling with abnormal embryogenesis [27,28], and severe sterol deprivation can indeed inhibit the processing of transfected Shh in cultured mammalian cells [29].']	(6305, 6602)	['CHEBI:16113', 'CHEBI_EXT:chemical_substance_or_polyatomic_entity', 'CHEBI_EXT:35222', 'CHEBI:15889', 'CL:0000010', 'CL:0000010', 'GO:0006695', 'GO:0006695', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO:0009790', 'GO:0009294', 'CL_GO_EXT:cell', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:40674', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'PR_EXT:000014841', 'SO_EXT:sequence_alteration_process']
15005800	38	['In the present studies, we characterized lung development in Dhcr7-/- embryos from E10.5 to birth.']	(6604, 6702)	['GO:0030324', 'GO:0030324', 'GO:0007567', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0000922']
15005800	39	['Our results showed that cholesterol deficiency, caused by loss of Dhcr7 activity, did not alter lung branching morphogenesis (early gestational stages, E9.5 to E14.5).']	(6703, 6870)	['CHEBI:16113', 'GO:0060441', 'GO:0060441', 'GO:0060441', 'GO:0007565', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'UBERON:0002048']
15005800	40	['However, lung saccular development was impaired, with arrested or partially developed epithelial tubules and delayed vascular development.']	(6871, 7009)	['GO:0060430', 'GO:0060430', 'GO:0060430', 'UBERON:0000116', 'UBERON:0000116', 'UBERON:0003914', 'UBERON:0003914', 'UBERON_EXT:vascular_system_or_vasculature_or_vessel']
15005800	41	['Differentiation of type II alveolar epithelial cells (AECs) appeared normal but differentiation of type I AECs was severely impaired.']	(7010, 7143)	['CL:0002063', 'CL:0002063', 'CL:0002063', 'CL:0002063', 'CL:0002063', 'CL:0002063', 'CL:0002063', 'CL:0002063', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'GO:0030154', 'GO:0030154', 'GO:0030154', 'GO_RO_EXT:developmental_differentiation_process', 'CL_GO_EXT:cell', 'UBERON:0003215', 'UBERON:0000483']
15005800	42	['Therefore, cholesterol deficiency resulted in a distinct late gestational lung hypoplasia, characterized by impaired sacculation with delayed type I AECs differentiation and immature vascular development.']	(7144, 7348)	['CHEBI:16113', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'GO:0007565', 'GO_RO_EXT:developmental_differentiation_process', 'UBERON:0002048', 'UBERON_EXT:vascular_system_or_vasculature_or_vessel']
15005800	43	['However, this study does not support the concept that the perturbation of Shh-Patched-Gli pathway was involved in the pathogenesis of developmental lung hypoplasia in Dhcr7-/- embryos.']	(7349, 7533)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'PR_EXT:Patched', 'PR_EXT:Gli', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0000922']
15005800	44	['Patterns of expression of Shh signaling cascade members were not altered, and processing of Shh appeared normal.']	(7534, 7646)	['GO:0010467', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'PR_EXT:000014841', 'PR_EXT:000014841', 'SO_EXT:sequence_alteration_process']
15005800	45	['Results\n\nBody growth retardation at late gestation stage in Dhcr7-/- embryos\n\nDhcr7-/- mice were born in the expected Mendelian ratios from heterozygous parents, but all of these pups died within 24 h and most within 14 h of birth [16].']	(7648, 7884)	['GO_EXT:biological_growth_entity_or_process', 'GO:0007565', 'GO:0007567', 'GO:0016265', 'GO:0007567', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'NCBITaxon_UBERON_EXT:pup', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON_EXT:body', 'UBERON:0000922', 'NCBITaxon_UBERON_EXT:pup']
15005800	46	['At birth, they were clearly smaller than wild-type or heterozygous littermates.']	(7885, 7964)	['GO:0007567', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality']
15005800	47	['An experienced investigator can pick out knockout pups based on this along with presence of hypoxia and their lack of spontaneous movement.']	(7965, 8104)	['GO_EXT:biological_movement_or_translocation_process', 'NCBITaxon_UBERON_EXT:pup', 'NCBITaxon_UBERON_EXT:pup']
15005800	48	['The breathing frequency in P0 Dhcr7-/- pups was markedly slower than control littermates (34 ± 7 breaths/min in Dhcr7-/-, n = 10 vs. 92 ± 16 breaths/min in controls, n = 32, p < 0.001) and the breathing was observed to be more irregular and shallow, with long periods of apnea.']	(8105, 8382)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon_UBERON_EXT:pup', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'NCBITaxon_UBERON_EXT:pup']
15005800	49	['To determine the gestational stage at which growth of the knockout embryos was affected, embryos were harvested at various stages of gestation and their body lengths compared between Dhcr7-/- and controls.']	(8384, 8589)	['GO:0007565', 'GO_EXT:biological_growth_entity_or_process', 'GO:0007565', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922', 'UBERON:0000922', 'UBERON_EXT:body']
15005800	50	['A linear increase in body length from E9.5 to E19.5 in control embryos was observed (Fig.']	(8590, 8679)	['UBERON_EXT:body', 'UBERON:0000922']
15005800	51	['1).']	(8680, 8683)	[]
15005800	52	['No significant differences in body length between wild-type and heterozygous embryos were noted (data not shown).']	(8684, 8797)	['SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON_EXT:body', 'UBERON:0000922']
15005800	53	['In contrast, knockout embryos showed comparable body length growth until E14.5~E16.5, then began to show a slower increase in length, such that by E17.5, this was statistically significant (18.87 ± 1.29 mm in controls, n = 15 compared to 16.69 ± 1.05 mm in Dhcr7-/-, n = 7, p < 0.05, Fig.']	(8798, 9086)	['GO_EXT:biological_growth_entity_or_process', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922', 'UBERON_EXT:body']
15005800	54	['1).']	(9087, 9090)	[]
15005800	55	['Figure 1\n\nBody length growth curves.']	(9092, 9128)	['GO_EXT:biological_growth_entity_or_process', 'UBERON_EXT:body']
15005800	56	['Body length growth vs. gestational days is as shown.']	(9129, 9181)	['GO_EXT:biological_growth_entity_or_process', 'GO:0007565', 'UBERON_EXT:body']
15005800	57	['Control embryos (filled triangles, wild-type and heterozygous embryos were pooled together as there were no differences between these two groups) and knockout embryos (filled circles) were as shown.']	(9182, 9380)	['SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0000922', 'UBERON:0000922', 'UBERON:0000922']
15005800	58	['The growth curve showed a linear increase from E9.5 to E19.5 in controls, but deviated at ~E14.5 in Dhcr7-/- embryos.']	(9381, 9498)	['GO_EXT:biological_growth_entity_or_process', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922']
15005800	59	['Body lengths at E17.5 (18.87 ± 1.29 mm in controls, n = 15 vs. 16.69 ± 1.05 mm in Dhcr7-/-, n = 7, p < 0.05), E18.5 (21.35 ± 1.05 mm in controls, n = 15 vs. 19.38 ± 0.9 mm in Dhcr7-/-, n = 5, p < 0.05) and E19.5 (23.4 ± 0.97 mm in controls, n = 13 vs. 20.3 ± 0.44 mm in Dhcr7-/-, n = 4, p < 0.05) were significantly decreased, compared to those in controls.']	(9499, 9856)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON_EXT:body']
15005800	60	['Results are expressed as mean ± s.d.']	(9857, 9893)	[]
15005800	61	['Dhcr7-/- embryos at late stages displayed pulmonary hypoplasia with delayed saccular development\n\nWet lung weights, as well as lung to body weight ratios were significantly lower in Dhcr7-/- at E18.5 compared to those in wild-type but not at E13.5 (Table 1).']	(9895, 10153)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0000323', 'UBERON:0000323', 'UBERON:0000323', 'UBERON:0000323', 'UBERON:0002048', 'UBERON:0000116', 'UBERON:0002048', 'UBERON:0002048', 'UBERON_EXT:body']
15005800	62	['Both body and lung weights were reduced, but lungs seemed to be more affected.']	(10154, 10232)	['UBERON_EXT:body', 'UBERON:0002048', 'UBERON:0002048']
15005800	63	['A representative figure of embryos at E10.5 and of the pups at birth was shown in Fig.']	(10233, 10319)	['GO:0007567', 'NCBITaxon_UBERON_EXT:pup', 'UBERON:0000922', 'NCBITaxon_UBERON_EXT:pup']
15005800	64	['2A and 2B.']	(10320, 10330)	[]
15005800	65	['Table 1\n\nWhole body and lung weights of mouse embryos\n\n* p < 0.05, compared to Dhcr7+/+.']	(10332, 10420)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'UBERON_EXT:body', 'UBERON:0002048', 'UBERON:0000922']
15005800	66	['BW, body weight; LW, lung weight.']	(10421, 10454)	['UBERON_EXT:body', 'UBERON:0002048']
15005800	67	['Figure 2\n\nEmbryonic size, lung morphology and histology at various stages of development.']	(10456, 10545)	['UBERON:0000922', 'UBERON:0002048']
15005800	68	['Panel A shows the size and general morphology of wild-type (+/+) and Dhcr7-/- (-/-) embryos at E10.5, without significant difference.']	(10546, 10679)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922']
15005800	69	['At P0, the knockout pups were significantly smaller and appeared hypoxic (panel B).']	(10680, 10763)	['NCBITaxon_UBERON_EXT:pup', 'NCBITaxon_UBERON_EXT:pup']
15005800	70	['Panel C shows dorsal views of lungs from knockout and wild-type at E13.5 and panel D those at P0.']	(10764, 10861)	['SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048']
15005800	71	['Cross-sectional examination at the cardiopulmonary level at E 20.5 (prior to birth) showed normal lobar septation, but lungs from knockout animals were smaller in size and had less distal sac space (cf.']	(10862, 11064)	['GO:0007567', 'NCBITaxon:33208', 'UBERON_EXT:heart_or_lung', 'UBERON:0009912', 'UBERON:0002048', 'UBERON:0009856']
15005800	72	['panels E and F).']	(11065, 11081)	[]
15005800	73	['Original magnification: Panels A and C, 2X; panels B and D, 0.7X; E and F, 2X.']	(11082, 11160)	[]
15005800	74	['Labels: r, right; l, left; b, bronchial; br, bronchiole; e, esophagus; pa, pulmonary artery; ra, right atrium; la, left atrium; rv, right ventricle; lv, left ventricle.']	(11161, 11329)	['UBERON_EXT:bronchiole_or_bronchus', 'UBERON_EXT:bronchiole_or_bronchus', 'UBERON:0002186', 'UBERON:0002186', 'UBERON:0001043', 'UBERON:0001043', 'UBERON:0002012', 'UBERON:0002012', 'UBERON:0002012', 'UBERON:0002078', 'UBERON:0002078', 'UBERON:0002078', 'UBERON:0002079', 'UBERON:0002079', 'UBERON:0002079', 'UBERON:0002080', 'UBERON:0002080', 'UBERON:0002080', 'UBERON:0002084', 'UBERON:0002084', 'UBERON:0002084']
15005800	75	['We examined the lungs for any gross morphological abnormalities.']	(11331, 11395)	['UBERON:0002048']
15005800	76	['The overall organogenesis of lungs was preserved in Dhcr7-/- pups; four right lung lobes and a single left lobe flanking the heart were easily seen on external examination at birth (Fig.']	(11396, 11582)	['GO:0030324', 'GO:0030324', 'GO:0030324', 'GO:0007567', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon_UBERON_EXT:pup', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'NCBITaxon_UBERON_EXT:pup', 'UBERON:0006518', 'UBERON:0006518', 'UBERON:0006518', 'UBERON:0009912', 'UBERON:0000948']
15005800	77	['2D).']	(11583, 11587)	[]
15005800	78	['Examination for lobation at E13.5 also showed comparable gross anatomy (Fig.']	(11588, 11664)	['UBERON:0001062']
15005800	79	['2C) between wild-type and knockout embryos.']	(11665, 11708)	['SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0000922']
15005800	80	['Histological analyses of the cardiopulmonary structures at E20.5, taken just before birth to avoid artifacts from lack of lung inflation, also confirmed normal gross anatomic development (Fig.']	(11709, 11901)	['GO:0007567', 'GO:0048856', 'GO:0048856', 'UBERON_EXT:heart_or_lung', 'UBERON:0002048', 'UBERON:0001062']
15005800	81	['2E and 2F).']	(11902, 11913)	[]
15005800	82	['Additionally, no cardiac defects were identified and this was confirmed by more detailed histological analyses (data not shown).']	(11914, 12042)	['UBERON:0000948']
15005800	83	['Thus, despite the obvious hypoxia frequently observed at birth of the knockout pups, major cardiac structural abnormalities were not observed to account for this phenotype.']	(12043, 12215)	['GO:0007567', 'NCBITaxon_UBERON_EXT:pup', 'NCBITaxon_UBERON_EXT:pup', 'UBERON:0000948']
15005800	84	['No distinguishable morphological differences were discernable between Dhcr7-/- and wild-type lungs at E10.5, E13.5, E14.5 and E16.5 at low (10X) or high (40X) magnifications (Fig.']	(12217, 12396)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048']
15005800	85	['3, panel A: a-h, data for E10.5 and E13.5 not shown).']	(12397, 12450)	[]
15005800	86	['However, from E17.5 onwards, lungs from knockout embryos appeared to have less saccular space and relatively more mesenchyme compared to wild-type lungs (Fig.']	(12451, 12609)	['SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048', 'UBERON:0000922', 'UBERON:0000116', 'UBERON:0003104', 'UBERON:0002048']
15005800	87	['3, panel A: I-x).']	(12610, 12627)	[]
15005800	88	['Lungs from control animals showed normal progression with formation of sac-like structures, the precursors of the alveoli (Fig.']	(12628, 12755)	['NCBITaxon:33208', 'UBERON:0002048', 'UBERON:0009856', 'UBERON:0003215']
15005800	89	['3, panel A: i, m, q and u).']	(12756, 12783)	[]
15005800	90	['In lungs from knockout embryos, expansion of epithelial tubules occurred but was significantly delayed (Fig.']	(12784, 12892)	['UBERON:0002048', 'UBERON:0000922', 'UBERON:0003914', 'UBERON:0003914']
15005800	91	['3, cf.']	(12893, 12899)	[]
15005800	92	['panel A: j, n, r, v with i, m, q and u).']	(12900, 12940)	[]
15005800	93	['Morphometric measurements of lung sections at E17.5, E18.5, E20.5 and in lungs from neonates showed that the proportion of terminal sac space area was significantly decreased in Dhcr7-/- lungs, compared wild-type lungs (Fig.']	(12941, 13165)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048', 'UBERON:0002048', 'PATO_UBERON_EXT:neonate_or_newborn', 'UBERON:0009856', 'UBERON:0002048', 'UBERON:0002048']
15005800	94	['3, panel B).']	(13166, 13178)	[]
15005800	95	['Interstitial mesenchyme appeared thicker and the lungs had less septation compared to control lungs.']	(13179, 13279)	['UBERON:0005169', 'UBERON:0003104', 'UBERON:0002048', 'UBERON:0002048']
15005800	96	["This 'thickening' of the alveoli may explain the hypoxia frequently seen in Dhcr7-/- pups at birth."]	(13280, 13379)	['GO:0007567', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon_UBERON_EXT:pup', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0003215', 'NCBITaxon_UBERON_EXT:pup']
15005800	97	['Figure 3\n\nHistological analyses of lungs at various embryonic stages.']	(13381, 13450)	['UBERON:0002048', 'UBERON_EXT:embryonic_stage_or_stage_part', 'UBERON_EXT:embryonic_stage_or_stage_part']
15005800	98	['Panel A indicates lung sections stained with H and E, and taken at various gestational stages as indicated.']	(13451, 13558)	['CHEBI:51686', 'CHEBI_EXT:eosin', 'GO:0007565', 'UBERON:0002048']
15005800	99	['The first two columns are at lower magnification (10X) and the last two columns at higher magnification (40X).']	(13559, 13669)	[]
15005800	100	['The first and third columns are representative sections from wild-type (+/+) embryos and the second and fourth columns from knockout (-/-) embryos.']	(13670, 13817)	['SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922', 'UBERON:0000922']
15005800	101	['No differences were visible at E14.5 or E16.5 (panel A, a-h).']	(13818, 13879)	[]
15005800	102	['Significant differences were visible from E17.5 onwards (panel A, i-x).']	(13880, 13951)	[]
15005800	103	['Distal tubules showed dilation and mesenchyme thinning, with progression of septation in wild-type lungs (panel A, i, m and q), whereas the knockout lungs showed less saccular structures and more mesenchyme (panel A, j, n and r).']	(13952, 14181)	['SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0003104', 'UBERON:0002048', 'UBERON:0002048', 'UBERON:0000116', 'UBERON:0003104']
15005800	104	['At higher magnifications of wild-type lungs (panel A, k, o and s), developing pre-alveoli and thinning mesenchyme (arrowheads) were seen but sections from knockout embryos showed a delay in this sequence of development (panel A, l, p and t).']	(14182, 14423)	['SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048', 'UBERON:0003215', 'UBERON:0003104', 'UBERON:0000922']
15005800	105	['At birth, lungs from knockout pups showed deficient septation and thick-walled mesenchyme (panel A, x, arrowheads).']	(14424, 14539)	['GO:0007567', 'NCBITaxon_UBERON_EXT:pup', 'UBERON:0002048', 'NCBITaxon_UBERON_EXT:pup', 'UBERON:0000060', 'UBERON:0003104']
15005800	106	['Labels: de, distal epithelium; m, mesenchyme; PA, pulmonary artery; a, pre-alveoli; b, bronchi.']	(14540, 14635)	['UBERON:0000483', 'UBERON:0003104', 'UBERON:0003104', 'UBERON:0002012', 'UBERON:0002012', 'UBERON:0002012', 'UBERON:0003215', 'UBERON:0003215', 'UBERON:0002185', 'UBERON:0002185']
15005800	107	['Panel B shows the morphometric analyses of lung terminal sac spaces in lungs at various gestational stages.']	(14636, 14743)	['GO:0007565', 'UBERON:0002048', 'UBERON:0009856', 'UBERON:0002048']
15005800	108	['A significant reduction in the terminal sac space was noted from E17.5 onwards.']	(14744, 14823)	['UBERON:0009856']
15005800	109	['Results are expressed as mean ± s.d.']	(14824, 14860)	[]
15005800	110	['Attenuated cell proliferation in late gestational Dhcr7-/- lungs\n\nDoes the loss of normal cholesterol biosynthesis lead to abnormalities of cell proliferation/division or cell death?']	(14862, 15044)	['CHEBI:16113', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO:0008283', 'GO:0008283', 'GO:0007565', 'GO:0006695', 'GO:0006695', 'GO:0008283', 'GO:0051301', 'GO:0008283', 'GO:0051301', 'GO:0008219', 'GO:0008219', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048']
15005800	111	['Cell proliferation was examined by immunostaining for PCNA and also by BrdU incorporation.']	(15045, 15135)	['CHEBI:472552', 'CL_GO_EXT:cell', 'GO:0008283', 'GO:0008283', 'CL_GO_EXT:cell', 'PR_EXT:000012421']
15005800	112	['Both PCNA and BrdU staining of wild-type and knockout lungs at early gestational stages (E13.5 and E14.5) showed comparable patterns (Fig.']	(15136, 15274)	['CHEBI:472552', 'GO:0007565', 'PR_EXT:000012421', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048']
15005800	113	['4, panels A-D).']	(15275, 15290)	[]
15005800	114	['However, a clear reduction of PCNA and BrdU labeling was visualized in distal lungs of knockout embryos at late gestational stages (E18.5 and E20.5, Fig.']	(15291, 15444)	['CHEBI:472552', 'CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process', 'GO:0007565', 'PR_EXT:000012421', 'CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process', 'UBERON:0002048', 'UBERON:0000922']
15005800	115	['4, panels E-H).']	(15445, 15460)	[]
15005800	116	['Attenuated PCNA labeling was also noted in knockout hearts at term (Fig.']	(15461, 15533)	['CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process', 'PR_EXT:000012421', 'CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process', 'UBERON:0000948']
15005800	117	['4, cf.']	(15534, 15540)	[]
15005800	118	['panels I and J).']	(15541, 15557)	[]
15005800	119	['When lungs were stained for pHH3, a marker of active cell division, a clear reduction of pHH3 expression in the epithelium of knockout lung was observed at E20.5 but not at E14.5 (Fig.']	(15558, 15742)	['CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'CL_GO_EXT:cell', 'GO:0051301', 'GO:0051301', 'GO:0010467', 'CL_GO_EXT:cell', 'CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'UBERON:0002048', 'UBERON:0000115', 'UBERON:0000115', 'UBERON:0000115']
15005800	120	['4, panels K, L, O and P).']	(15743, 15768)	[]
15005800	121	['In contrast, using the TUNEL assay, no apparent differences in cell apoptosis rates were observed between wild-type and knockout lungs at E18.5 (Fig.']	(15769, 15918)	['CL_GO_EXT:cell', 'GO:0006915', 'GO:0006915', 'CL_GO_EXT:cell', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048']
15005800	122	['4, cf.']	(15919, 15925)	[]
15005800	123	['panels M and N).']	(15926, 15942)	[]
15005800	124	['Thus, at the late gestational stages, cell proliferation/division was impaired in knockout embryos with no increase in cell death rates.']	(15943, 16079)	['CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO:0007565', 'GO:0008283', 'GO:0051301', 'GO:0008283', 'GO:0051301', 'GO:0008219', 'GO:0008219', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'UBERON:0000922']
15005800	125	['Figure 4\n\nAnalyses of cell proliferation, cell division and cell death.']	(16081, 16152)	['CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO:0008283', 'GO:0008283', 'GO:0051301', 'GO:0051301', 'GO:0008219', 'GO:0008219', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell']
15005800	126	['Cell proliferation (PCNA: panels A, B, E and F; BrdU: panels C, D, G and H), cell division (pHH3: panels K, L, O and P) and cell death (TUNEL: panels M and N) were analyzed by immunostaining on lung sections at early and late gestational stages.']	(16153, 16398)	['CHEBI:472552', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO:0008283', 'GO:0008283', 'GO:0051301', 'GO:0051301', 'GO:0008219', 'GO:0008219', 'GO:0007565', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000012421', 'UBERON:0002048']
15005800	127	['Both PCNA and BrdU labeled cells in both epithelial and mesenchymal regions were comparable at early stages (E14.5 for PCNA and E13.5 for BrdU) between wild-type (+/+) and knockout (-/-) lungs.']	(16399, 16592)	['CHEBI:472552', 'CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process', 'CHEBI:472552', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000012421', 'PR_EXT:000012421', 'CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000483', 'UBERON:0003104', 'UBERON:0002048']
15005800	128	['Positively stained cells in distal lungs at late stage (E20.5 for PCNA and E18.5 for BrdU) from knockout lungs were markedly reduced, compared with wild-type.']	(16593, 16751)	['CHEBI:472552', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000012421', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048', 'UBERON:0002048']
15005800	129	['PCNA labeling of cardiac muscle was also attenuated in knockout embryos at E20.5 (cf.']	(16752, 16837)	['CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process', 'PR_EXT:000012421', 'CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process', 'UBERON:0001133', 'UBERON:0001133', 'UBERON:0000922']
15005800	130	['panels I and J).']	(16838, 16854)	[]
15005800	131	['No apparent differences in TUNEL immunostaining were observed in lung sections at E18.5 between wild-type and knockout.']	(16855, 16974)	['SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048']
15005800	132	['The pHH3 immunostaining was comparable between wild-type and knockout lungs at E14.5, and the lungs from wild-type at E20.5 showed a high index of positive cells, whereas lungs from knockout showed a apparent reduced staining pattern.']	(16975, 17209)	['CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048', 'UBERON:0002048', 'UBERON:0002048']
15005800	133	['Note the dividing cells are mainly epithelial.']	(17210, 17256)	['CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'UBERON:0000483']
15005800	134	['Original magnification: A-D and G-N are 20X; E, F, O and P are 40X.']	(17257, 17324)	[]
15005800	135	['Sterol content of developing lungs in Dhcr7 deficient mice\n\nMarkedly elevated 7-DHC/8-DHC levels and reduced body cholesterol levels have been reported previously in Dhcr7-/- P0 mice [16,17].']	(17326, 17517)	['CHEBI:15889', 'CHEBI:17759', 'CHEBI:17759', 'CHEBI:17759', 'CHEBI:16113', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'NCBITaxon:10088', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON_EXT:body']
15005800	136	['A significant amount of cholesterol was detectable in lungs of Dhcr7-/- mice, comprising ~60% and ~30% of total tissue sterols at E13.5 and neonate, respectively.']	(17518, 17680)	['CHEBI:16113', 'CHEBI:15889', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0000479', 'PATO_UBERON_EXT:neonate_or_newborn']
15005800	137	['In contrast to the doubling of cholesterol in the lungs of wild type embryos (1.82 mg/g tissue at E13.5 to 3.55 mg/g tissue at P0), cholesterol content in the lungs of Dhcr7 null embryos remained at almost constant low levels between E13.5 and P0 gestational stages (Fig.']	(17681, 17952)	['CHEBI:16113', 'CHEBI:16113', 'GO:0007565', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:sequence_nullness', 'UBERON:0002048', 'UBERON:0000922', 'UBERON:0000479', 'UBERON:0000479', 'UBERON:0002048', 'UBERON:0000922']
15005800	138	['5).']	(17953, 17956)	[]
15005800	139	['There was a progressive increase in 7-DHC and 8-DHC; the latter is generated as a spontaneous isomerization from the former.']	(17957, 18081)	['CHEBI:17759', 'CHEBI:17759', 'CHEBI:17759', 'MOP:0000789']
15005800	140	['Total sterols at birth were reduced in lungs of the Dhcr7 null mice, but were only lower by ~30% (Fig.']	(18082, 18184)	['CHEBI:15889', 'GO:0007567', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness', 'UBERON:0002048']
15005800	141	['5, see values for P0 mice).']	(18185, 18212)	['NCBITaxon:10088']
15005800	142	['Figure 5\n\nSterol analyses of embryonic lungs.']	(18214, 18259)	['CHEBI:15889', 'UBERON:0000922', 'UBERON:0002048']
15005800	143	['Sterol contents, including cholesterol (black bars) and 7DHC/8DHC (white bars), were quantitated by GC-MS in the lungs from wild-type (+/+) and knockout (-/-) embryos.']	(18260, 18427)	['CHEBI:15889', 'CHEBI:16113', 'CHEBI:17759', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0000922']
15005800	144	['Results are expressed as mean ± s.d and the number of lungs analyzed is as indicated.']	(18428, 18513)	['UBERON:0002048']
15005800	145	['Total sterols were lower at all stages in knockout lungs, with almost no increase in cholesterol content with time (black bars), but there was a progressive increment in the precursor sterols, 7DHC/8DHC (open bars), with increasing gestation.']	(18514, 18756)	['CHEBI:15889', 'CHEBI:16113', 'CHEBI:15889', 'CHEBI:17759', 'GO:0007565', 'UBERON:0002048']
15005800	146	['Cholesterol is absolutely required for steroid hormone synthesis by the adrenal glands.']	(18758, 18845)	['CHEBI:16113', 'CHEBI:26764', 'CHEBI:26764', 'GO:0042446', 'GO:0042446', 'CHEBI_GO_EXT:hormone', 'UBERON:0002369', 'UBERON:0002369']
15005800	147	['Adrenal insufficiency, as has been reported in some severe cases of SLOS patients, could be responsible for the lung hypoplasia and perinatal lethality [30].']	(18846, 19003)	['GO:0007567', 'GO_EXT:fatality_or_lethality', 'UBERON:0002369', 'UBERON:0002048', 'UBERON:0012101']
15005800	148	['Steroids, but particularly corticosteroids, are necessary for lung maturation, especially the synthesis and secretion of surfactant components [31].']	(19004, 19152)	['CHEBI:35341', 'CHEBI:50858', 'CHEBI_EXT:35195', 'GO_PATO_EXT:biological_maturation', 'GO_EXT:secretion_entity_or_process', 'UBERON:0002048']
15005800	149	['We determined plasma corticosterone levels in P0 mice within 12 h of birth.']	(19153, 19228)	['CHEBI:16827', 'GO:0007567', 'NCBITaxon:10088', 'UBERON:0001969']
15005800	150	['Wild type P0 mice had corticosterone levels of 158 ± 50 ng/ml (n = 11), compared with 225 ± 50 ng/ml (n = 7, p < 0.01) in Dhcr7-/- P0 mice.']	(19229, 19368)	['CHEBI:16827', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'NCBITaxon:10088', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence']
15005800	151	['Thus, the corticosterone levels in Dhcr7-/- mice were not decreased, but increased by ~40%.']	(19369, 19460)	['CHEBI:16827', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence']
15005800	152	['However, since these P0 mice were dying, perhaps this increase was sub-optimal given the stress.']	(19461, 19557)	['GO:0016265', 'NCBITaxon:10088']
15005800	153	['Nevertheless, an absolute lack of corticosterone was not present in these knockout pups.']	(19558, 19646)	['CHEBI:16827', 'NCBITaxon_UBERON_EXT:pup', 'NCBITaxon_UBERON_EXT:pup']
15005800	154	['To further rule out any effects of corticosterone deficiency on lung immaturity, we examined lungs for surfactant protein expression.']	(19648, 19781)	['CHEBI:16827', 'CHEBI_EXT:35195', 'CHEBI_PR_EXT:protein', 'GO:0010467', 'CHEBI_PR_EXT:protein', 'UBERON:0002048', 'UBERON:0002048']
15005800	155	['Surfactant protein C, as determined by IHC, was comparable in lung sections from wild-type or Dhcr7 null embryos at either E18.5 or at E20.5 gestational ages (Fig.']	(19782, 19945)	['CHEBI_EXT:35195', 'CHEBI_PR_EXT:protein', 'GO:0007565', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014774', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:sequence_nullness', 'UBERON:0002048', 'UBERON:0000922']
15005800	156	['6, panel A).']	(19946, 19958)	[]
15005800	157	['Northern analyses for SP-A, SP-B, SP-C or SP-D showed no significantly differences between wild-type and Dhcr7 null mice at term (Fig.']	(19959, 20093)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'PR_EXT:000015945', 'PR_EXT:000015945', 'PR_EXT:000015945', 'PR_EXT:000014773', 'PR_EXT:000014773', 'PR_EXT:000014773', 'PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014775', 'PR_EXT:000014775', 'PR_EXT:000014775', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:sequence_nullness']
15005800	158	['6, panel B).']	(20094, 20106)	[]
15005800	159	['Thus, surfactant protein expression was not altered by Dhcr7 deficiency.']	(20107, 20179)	['CHEBI_EXT:35195', 'CHEBI_PR_EXT:protein', 'GO:0010467', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'CHEBI_PR_EXT:protein', 'GO_PR_EXT:7_dehydrocholesterol_reductase']
15005800	160	['Figure 6\n\nSurfactant protein expression in lungs.']	(20181, 20230)	['CHEBI_EXT:35195', 'CHEBI_PR_EXT:protein', 'GO:0010467', 'CHEBI_PR_EXT:protein', 'UBERON:0002048']
15005800	161	['Panel A shows the immunostaining patterns for SP-C in lungs at E18.5 and E20.5 from wild-type (+/+) and knockout (-/-) embryos.']	(20231, 20358)	['PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014774', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0000922']
15005800	162	['No significant differences in the patterns of SP-C staining were evident between wild-type and knockout lungs (panel A, a-d).']	(20359, 20484)	['PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014774', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048']
15005800	163	['Note that the underdeveloped epithelial tubules in knockout lungs also expressed SP-C (panel A, b and d, arrowheads), indicating normal type II AECs differentiation.']	(20485, 20650)	['CL:0002063', 'CL:0002063', 'CL:0002063', 'GO:0010467', 'GO_RO_EXT:developmental_differentiation_process', 'PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014774', 'UBERON:0003914', 'UBERON:0003914', 'UBERON:0002048']
15005800	164	['Original magnification: 10X.']	(20651, 20679)	[]
15005800	165	['Panel B, left-hand panel, shows a representative result from Northern analyses of total RNA from wild-type, heterozygous and knockout P0 lungs for SP-A, SP-B, SP-C and SP-D expression.']	(20680, 20864)	['CHEBI_SO_EXT:RNA', 'GO:0010467', 'PR_EXT:000015945', 'PR_EXT:000015945', 'PR_EXT:000015945', 'PR_EXT:000014773', 'PR_EXT:000014773', 'PR_EXT:000014773', 'PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014775', 'PR_EXT:000014775', 'PR_EXT:000014775', 'CHEBI_SO_EXT:RNA', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048']
15005800	166	['Densitometry analyses showed the relative expression (n = 3, mean ± s.d.)']	(20865, 20938)	['GO:0010467']
15005800	167	['of these surfactant protein mRNAs were not significantly different between these three genotypes.']	(20939, 21036)	['CHEBI_EXT:35195', 'CHEBI_PR_EXT:protein', 'CHEBI_SO_EXT:mRNA', 'CHEBI_PR_EXT:protein', 'CHEBI_SO_EXT:mRNA', 'SO_EXT:genotype_or_entity_with_genotype']
15005800	168	['Dhcr7-/- lungs showed abnormal differentiation of type I alveolar epithelial cells (AECs)\n\nAt E20.5, the distal lung of wild type embryos consisted of saccular structures lined by flat type I AECs, and by cuboidal surfactant-producing type II AECs (Fig.']	(21038, 21291)	['CHEBI_EXT:35195', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002063', 'CL:0002063', 'CL:0002063', 'CL:0002063', 'GO:0030154', 'GO:0030154', 'GO:0030154', 'CL_GO_EXT:cell', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048', 'UBERON:0003215', 'UBERON:0000483', 'UBERON:0002048', 'UBERON:0000922', 'UBERON:0000116']
15005800	169	['7A).']	(21292, 21296)	[]
15005800	170	['In contrast, the formation of these typical saccules was impaired in Dhcr7 deficient lungs.']	(21297, 21388)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'UBERON:0000116', 'UBERON:0002048']
15005800	171	['Instead, these saccular structures were lined by a low columnar epithelium that lacked flattened type I-like cells with the presence of many undeveloped or arrested epithelial tubules (Fig.']	(21389, 21578)	['CL:0002062', 'CL:0002062', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'UBERON:0000116', 'UBERON:0012274', 'UBERON:0012274', 'UBERON:0003914', 'UBERON:0003914']
15005800	172	['7B).']	(21579, 21583)	[]
15005800	173	['Consistent with disruption of type I AECs differentiation was the dramatic reduction of expression of T1α, an apical membrane protein marker of lung type I AECs (Fig.']	(21584, 21750)	['CHEBI_PR_EXT:protein', 'CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'GO_RO_EXT:developmental_differentiation_process', 'GO:0010467', 'GO:0016324', 'GO:0016324', 'PR_EXT:000012516', 'CHEBI_PR_EXT:protein', 'CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'UBERON:0002048']
15005800	174	['7, cf.']	(21751, 21757)	[]
15005800	175	['panels C and D).']	(21758, 21774)	[]
15005800	176	['Decreased immunostaining for AQP5, another type I AEC marker, was also noted in Dhcr7 deficient lungs at E20.5, compared to control lungs (Fig.']	(21775, 21918)	['CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000004185', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'UBERON:0002048', 'UBERON:0002048']
15005800	177	['7, cf.']	(21919, 21925)	[]
15005800	178	['panels E and F).']	(21926, 21942)	[]
15005800	179	['Megalin, a low density lipoprotein receptor (LDLR) gene family member, is expressed by embryonic epithelial cells and can function as an endocytic Shh receptor [32].']	(21943, 22108)	['CHEBI_GO_EXT:low_density_lipoprotein_particle', 'CHEBI_GO_EXT:low_density_lipoprotein_particle', 'CHEBI_GO_EXT:low_density_lipoprotein_particle', 'CL:0002321', 'CL:0000066', 'CL:0000066', 'CL:0002321', 'GO:0010467', 'GO:0006897', 'CHEBI_GO_EXT:low_density_lipoprotein_particle', 'CHEBI_GO_EXT:low_density_lipoprotein_particle', 'CHEBI_GO_EXT:low_density_lipoprotein_particle', 'CL_GO_EXT:cell', 'GO_PR_EXT:low_density_lipoprotein_receptor', 'GO_PR_EXT:low_density_lipoprotein_receptor', 'GO_PR_EXT:low_density_lipoprotein_receptor', 'GO_PR_EXT:low_density_lipoprotein_receptor', 'GO_PR_EXT:low_density_lipoprotein_receptor', 'GO_EXT:0004872', 'PR_EXT:000009921', 'GO_PR_EXT:low_density_lipoprotein_receptor', 'GO_PR_EXT:low_density_lipoprotein_receptor', 'GO_PR_EXT:low_density_lipoprotein_receptor', 'GO_PR_EXT:low_density_lipoprotein_receptor', 'GO_PR_EXT:low_density_lipoprotein_receptor', 'PR_EXT:000014841', 'SO_EXT:0000704', 'UBERON:0000922', 'UBERON:0000483']
15005800	180	['Megalin was highly expressed on the distal epithelium at E20.5 from wild-type lungs, as well as type I AECs lining the developed saccules (Fig.']	(22109, 22252)	['CL:0002062', 'CL:0002062', 'CL:0002062', 'GO:0010467', 'PR_EXT:000009921', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0000483', 'UBERON:0002048', 'UBERON:0000116']
15005800	181	['7G).']	(22253, 22257)	[]
15005800	182	['In contrast, though megalin staining was detected in developing saccules in knockout embryonic lungs, its expression was confined to undifferentiated cuboidal cells (Fig.']	(22258, 22428)	['CL_GO_EXT:cell', 'GO:0010467', 'GO_PATO_RO_EXT:developmental_differentiation_process_or_quality', 'CL_GO_EXT:cell', 'PR_EXT:000009921', 'UBERON:0000116', 'UBERON:0000922', 'UBERON:0002048']
15005800	183	['7H), further indicating a delay in type I AECs differentiation in the knockout lungs.']	(22429, 22514)	['CL:0002062', 'CL:0002062', 'CL:0002062', 'GO_RO_EXT:developmental_differentiation_process', 'UBERON:0002048']
15005800	184	['Figure 7\n\nCharacterization of type I AECs differentiation.']	(22516, 22574)	['CL:0002062', 'CL:0002062', 'CL:0002062', 'GO_RO_EXT:developmental_differentiation_process']
15005800	185	['The normal distal saccules of wild-type (+/+) at near term (E20.5) showed typical type I (t1) and type II (t2) epithelial cells (panel A, arrowheads), but knockout (-/-) littermate lungs showed less developed saccules lined by columnar epithelial cells (panel B, black arrowheads), with partially arrested tubules in the distal lung (panel B, green arrowheads).']	(22575, 22936)	['CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002063', 'CL:0002063', 'CL:0002063', 'CL:0002062', 'CL:0002063', 'CL:0002063', 'CL:0002062', 'CL:0002062', 'CL:0002063', 'CL:0002063', 'CL:0002062', 'CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000116', 'UBERON:0000483', 'UBERON:0002048', 'UBERON:0000116', 'UBERON:0012274', 'UBERON:0012274', 'UBERON:0002048']
15005800	186	['Immunostaining for type I cell markers T1α and AQP5 demonstrated an intense staining in flat epithelial cells in wild-type lungs at E20.5 (panels C and E, arrowheads).']	(22937, 23104)	['CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000012516', 'PR_EXT:000004185', 'CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0000483', 'UBERON:0002048']
15005800	187	['In contrast, in knockout littermate lungs, T1α and AQP5 staining was dramatically decreased (panels D and F, arrowheads).']	(23105, 23226)	['PR_EXT:000012516', 'PR_EXT:000004185', 'UBERON:0002048']
15005800	188	['Megalin expression (Meg) was detected in the airway epithelial cells, but not in proximal bronchiole epithelial cells (data not shown) in the lungs from both wild-type and knockout at E20.5.']	(23227, 23417)	['CL:0000066', 'CL:0000066', 'CL:0000066', 'CL:0000066', 'GO:0010467', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000009921', 'PR_EXT:000009921', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0001005', 'UBERON:0000483', 'UBERON:0002186', 'UBERON:0000483', 'UBERON:0002048']
15005800	189	['The elongated megalin-positive epithelial cells, lining the normally developed sacculi, were readily evident in many areas of the wild-type lungs.']	(23418, 23564)	['CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'PR_EXT:000009921', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0000483', 'UBERON:0000116', 'UBERON:0002048']
15005800	190	['In contrast, the terminal epithelial cells positively stained by megalin antibodies in knockout lungs were comprised mainly of undifferentiated cuboidal cells (compare the arrowheads in G and H).']	(23565, 23760)	['CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'GO_PATO_RO_EXT:developmental_differentiation_process_or_quality', 'CL_GO_EXT:cell', 'GO:0042571', 'CL_GO_EXT:cell', 'PR_EXT:000009921', 'UBERON:0000483', 'UBERON:0002048']
15005800	191	['Original magnification: A, B, G and H are 60X, C-F are 40X.']	(23761, 23820)	[]
15005800	192	['Delayed vascular development in Dhcr7-/- lungs\n\nThere is a close relationship between blood vessel development and lung structural development.']	(23822, 23965)	['GO:0001568', 'GO:0001568', 'GO:0001568', 'GO:0060425', 'GO:0060425', 'GO:0060425', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON_EXT:vascular_system_or_vasculature_or_vessel', 'UBERON:0002048', 'UBERON:0001981', 'UBERON:0001981', 'UBERON:0002048']
15005800	193	['At later lung developmental stages, timed capillary bed development is essential for the formation of mature alveolar gas-exchange, with a loss of mesenchyme separating the capillary beds and the AECs [19].']	(23966, 24172)	['CL:0010003', 'GO:0030324', 'GO:0030324', 'GO:0007585', 'GO:0007585', 'GO:0007585', 'UBERON:0002048', 'UBERON:0013141', 'UBERON:0013141', 'UBERON:0003215', 'UBERON:0003104', 'UBERON:0013141', 'UBERON:0013141']
15005800	194	['In Dhcr7-/- lungs at late gestational stages, the relative abundance of mesenchyme was consistent with the general arrest in sacculation.']	(24173, 24310)	['GO:0007565', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0003104']
15005800	195	['To investigate whether the delayed lung sacculation also involved abnormal blood vessel development, immunostaining for the α-isoform of caveolin-1 (cav-1α) and platelet endothelial cell adhesion molecular (PECAM-1) were performed on sections from wild-type and Dhcr7-/- lungs.']	(24311, 24588)	['CHEBI_EXT:polyatomic_entity_or_group', 'CL:0000233', 'CL:0000115', 'CL:0000115', 'GO:0001568', 'GO:0001568', 'GO:0001568', 'GO_PATO_EXT:biological_adhesion_entity_or_process', 'CL_GO_EXT:cell', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000001904', 'PR_EXT:000001904', 'PR_EXT:000001904', 'PR_EXT:000001904', 'PR_EXT:000001904', 'PR_EXT:000001904', 'PR_EXT:000001904', 'PR_EXT:000001904', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:0001060', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0001981', 'UBERON:0001981', 'UBERON:0001986', 'UBERON:0002048']
15005800	196	['In the developing lung, cav-1α is expressed strictly in the endothelium of developing capillary and blood vessels.']	(24589, 24703)	['GO:0010467', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'UBERON:0002048', 'UBERON:0001915', 'UBERON:0004638', 'UBERON:0001915', 'UBERON:0004638', 'UBERON:0001915', 'UBERON:0004638', 'UBERON:0001915', 'UBERON:0004638']
15005800	197	['Cav-1α is present in the terminally differentiated type I AECs, but is not detectable in its progenitors or type II AECs [33].']	(24704, 24830)	['CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002063', 'CL:0002063', 'CL:0002063', 'GO_PATO_RO_EXT:developmental_differentiation_process_or_quality', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209']
15005800	198	['At E14.5, both the epithelium and mesenchyme were negative for cav-1α staining, and cav-1α was detected in the developing blood vessels and capillaries, with no differences observed between wild-type and Dhcr7-/- lungs (Fig.']	(24831, 25055)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000483', 'UBERON:0003104', 'UBERON:0001981', 'UBERON:0001981', 'UBERON:0001982', 'UBERON:0002048']
15005800	199	['8, panels A and B).']	(25056, 25075)	[]
15005800	200	['Cav-1α immunostaining demonstrated that the vascular development proceeded rapidly during saccular stages in normal lungs (E17.5 and E20.5).']	(25076, 25216)	['PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'UBERON_EXT:vascular_system_or_vasculature_or_vessel', 'UBERON:0000116', 'UBERON:0002048']
15005800	201	['In near-term normal lungs (E20.5), an extensive vascular network, associated with markedly thinned septation walls of well-developed alveoli and close apposition to flat type I AECs, was observed (Fig.']	(25217, 25418)	['CL:0002062', 'CL:0002062', 'CL:0002062', 'UBERON:0002048', 'UBERON:0002049', 'UBERON:0002049', 'UBERON:0000060', 'UBERON:0003215']
15005800	202	['8, panels C and E).']	(25419, 25438)	[]
15005800	203	['In contrast, the cav-1α patterns in lungs from Dhcr7-/- embryos revealed a relatively undeveloped pulmonary capillary bed (Fig.']	(25439, 25566)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0000922', 'UBERON:0002048', 'UBERON:0013141', 'UBERON:0013141']
15005800	204	['8, panels D and F).']	(25567, 25586)	[]
15005800	205	['At E20.5, cav-1α stained cells in knockout lungs were embedded in a relatively thick mesenchyme surrounding undeveloped epithelial tubules, and these epithelial cells remained cuboidal, instead of flattening out (Fig.']	(25587, 25804)	['CL_GO_EXT:cell', 'CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'UBERON:0002048', 'UBERON:0003104', 'UBERON:0003914', 'UBERON:0003914', 'UBERON:0000483']
15005800	206	['8, panel F).']	(25805, 25817)	[]
15005800	207	['PECAM-1 staining at E20.5 confirmed the delayed lung vascular development at these late gestational stages in Dhcr7 deficient embryos (Fig.']	(25818, 25957)	['GO:0007565', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000001904', 'PR_EXT:000001904', 'PR_EXT:000001904', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'UBERON:0002048', 'UBERON_EXT:vascular_system_or_vasculature_or_vessel', 'UBERON:0000922']
15005800	208	['8, cf.']	(25958, 25964)	[]
15005800	209	['panels G and H).']	(25965, 25981)	[]
15005800	210	['Figure 8\n\nImmunostaining patterns for caveolin-1α and PECAM-1 in lung sections.']	(25983, 26062)	['PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000001904', 'PR_EXT:000001904', 'PR_EXT:000001904', 'UBERON:0002048']
15005800	211	['Cav-1α staining was compared at E14.5, E17.5 and E20.5 stages of development.']	(26063, 26140)	['PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209']
15005800	212	['Both the epithelium and mesenchyme were negative for cav-1α at E14.5.']	(26141, 26210)	['PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'UBERON:0000483', 'UBERON:0003104']
15005800	213	['Developing blood vessels (red arrowheads) and capillaries (arrows) (panels A and B) were stained positively for cav-1α, but the staining patterns between wild-type (+/+) and knockout (-/-) lungs were not altered.']	(26211, 26423)	['PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0001981', 'UBERON:0001981', 'UBERON:0001982', 'UBERON:0002048']
15005800	214	['Cav-1α was also detected at the proximal bronchiole sub-epithelial matrices (panels A-D, black arrowheads).']	(26424, 26531)	['PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'UBERON:0002186', 'UBERON:0000483']
15005800	215	['At E17.5, the airway epithelium, negative for cav-1α staining, was surrounded by rings of cav-1α positively stained capillary networks (panels C and D, arrows).']	(26532, 26692)	['PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'UBERON:0001005', 'UBERON:0000483', 'UBERON:0001982']
15005800	216	['Cav-1α expression patterns in lungs from knockout embryos at E17.5 were similar to wild-type embryos, but relative less capillary bed was noted in knockout lungs (cf.']	(26693, 26859)	['GO:0010467', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048', 'UBERON:0000922', 'UBERON:0000922', 'UBERON:0013141', 'UBERON:0013141', 'UBERON:0002048']
15005800	217	['panels C and D).']	(26860, 26876)	[]
15005800	218	['At E20.5 of wild-type lungs, both cav-1α and PECAM-1 staining demonstrated an extensive vascular network in the well developed saccules, with staining observed in close proximity to flat epithelial cells lining the air spaces (panels E and G, arrows).']	(26877, 27128)	['CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000001904', 'PR_EXT:000001904', 'PR_EXT:000001904', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048', 'UBERON:0002049', 'UBERON:0002049', 'UBERON:0000116', 'UBERON:0000483']
15005800	219	['However, delayed vascular development was observed in knockout lungs, showing capillaries (panels F and H, arrows) of the knockout lungs at E20.5 were embedded in a relatively thick mesenchyme around the undeveloped epithelial tubules in which the epithelial cells were remained cuboidal (arrowheads).']	(27129, 27430)	['CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'UBERON_EXT:vascular_system_or_vasculature_or_vessel', 'UBERON:0002048', 'UBERON:0016405', 'UBERON:0016405', 'UBERON:0016405', 'UBERON:0003104', 'UBERON:0003914', 'UBERON:0003914', 'UBERON:0000483']
15005800	220	['Original magnification: A-D are 20X; E-H are 40X.']	(27431, 27480)	[]
15005800	221	['Is the pattern of sonic hedgehog expression or signaling altered in Dhcr7-/- embryos?']	(27482, 27567)	['GO:0007224', 'GO:0010467', 'GO:0007224', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'PR_EXT:000014841', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922']
15005800	222	['Shh is critical for normal embryonic development and its autoprocessing, resulting in a cholesterol molecule covalently attached at its C-terminus, is a necessary step for its regulated signaling function [23,34].']	(27569, 27782)	['CHEBI:16113', 'CHEBI:36357', 'CHEBI_SO_EXT:C_terminus_or_C_terminal_region', 'CHEBI_SO_EXT:C_terminus_or_C_terminal_region', 'CHEBI_SO_EXT:C_terminus_or_C_terminal_region', 'GO:0009790', 'GO:0009790', 'GO:0016540', 'GO:0065007', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'MOP:0000779', 'MOP:0000779', 'PR_EXT:000014841', 'SO_EXT:sequence_alteration_process', 'CHEBI_SO_EXT:C_terminus_or_C_terminal_region', 'CHEBI_SO_EXT:C_terminus_or_C_terminal_region', 'CHEBI_SO_EXT:C_terminus_or_C_terminal_region', 'UBERON:0000922']
15005800	223	['Thus, disruption of cholesterol biosynthesis could conceivably disrupt its pattern of distribution and thus affect normal development.']	(27783, 27917)	['CHEBI:16113', 'GO:0006695', 'GO:0006695']
15005800	224	['To determine whether aberrant expression of Shh contributed to the Dhcr7-/- lung phenotype, distribution of Shh in the Dhcr7-/- and wild-type lungs was assessed from E10.5 to P0 by IHC using Shh-N peptide antibody.']	(27918, 28132)	['CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:peptide_or_peptide_region', 'GO:0010467', 'GO:0042571', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:peptide_or_peptide_region', 'UBERON:0002048', 'UBERON:0002048']
15005800	225	['At E10.5, the distribution of Shh was detected in the epithelial cells of lung buds (Fig.']	(28133, 28222)	['CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'PR_EXT:000014841', 'UBERON:0000483', 'UBERON:0000118', 'UBERON:0000118']
15005800	226	['9, left panel: C and D), as well as in the more typical Shh-expressing locations, such as the floor plate, notochord and mid gut (Fig.']	(28223, 28357)	['GO:0010467', 'PR_EXT:000014841', 'UBERON:0003079', 'UBERON:0003079', 'UBERON:0002328', 'UBERON:0001045', 'UBERON:0001045']
15005800	227	['9, left panel: A-D).']	(28358, 28378)	[]
15005800	228	['Importantly, no differences between Dhcr7-/- and control embryos were noted.']	(28379, 28455)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922']
15005800	229	['Likewise, examination of lung sections from increasing gestational ages through to birth showed no significant differences between wild-type and Dhcr7 deficient tissues.']	(28456, 28625)	['GO:0007565', 'GO:0007567', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048', 'UBERON:0000479']
15005800	230	['The patterns of staining observed were comparable to those previously reported for Shh in mouse lungs [25].']	(28626, 28733)	['NCBITaxon:10088', 'PR_EXT:000014841', 'UBERON:0002048']
15005800	231	['Figure 9\n\nShh and Ptch expression patterns at different gestational stages in Dhcr7-/- and wild-type mice.']	(28735, 28841)	['GO:0010467', 'GO:0007565', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'PR_EXT:000014841', 'PR_EXT:Patched', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality']
15005800	232	['Left panel shows the Shh immunostaining patterns using an antibody to Shh N-peptide at various gestational stages as indicated by the legend on the y-axis.']	(28842, 28997)	['CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:peptide_or_peptide_region', 'GO:0007565', 'GO:0042571', 'PR_EXT:000014841', 'PR_EXT:000014841', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:peptide_or_peptide_region']
15005800	233	['There were no significant differences noted at any of the stages examined between wild-type (+/+) and knockout (-/-) embryos.']	(28998, 29123)	['SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922']
15005800	234	['At E10.5, Shh was detected in the floor plate (fp), notochord (nc) (A and B), mid-gut (mg) and the epithelial buds of lungs (lb) (C and D).']	(29124, 29263)	['PR_EXT:000014841', 'UBERON:0003079', 'UBERON:0003079', 'UBERON:0003079', 'UBERON:0002328', 'UBERON:0002328', 'UBERON:0001045', 'UBERON:0001045', 'UBERON:0001045', 'UBERON:0001045', 'UBERON:0000483', 'UBERON:0000118', 'UBERON:0000118', 'UBERON:0000118', 'UBERON:0000118']
15005800	235	['Shh staining was restricted to epithelial cells in the distal region of the primordial tubes of lungs at E13.5 and E15.5.']	(29264, 29385)	['CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'PR_EXT:000014841', 'UBERON:0000483', 'UBERON:0000025', 'UBERON:0002048']
15005800	236	['Note that proximal epithelial cells of primordial tubes were not immunostained for Shh (E and F, arrows).']	(29386, 29491)	['CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'PR_EXT:000014841', 'UBERON:0000483', 'UBERON:0000025']
15005800	237	['Shh was detected in the lung epithelial cells on E18.5, and mainly in the conducting airways in the neonates.']	(29492, 29601)	['CL:0000082', 'CL:0000082', 'CL:0000082', 'CL_GO_EXT:cell', 'PR_EXT:000014841', 'UBERON:0000115', 'UBERON:0000115', 'UBERON:0001005', 'PATO_UBERON_EXT:neonate_or_newborn']
15005800	238	['Original magnifications: A~H, K and L are 10X, I and J are 20X.']	(29602, 29665)	[]
15005800	239	['Right panel shows the patterns of Ptch IHC at various gestational stages.']	(29666, 29739)	['GO:0007565', 'PR_EXT:Patched']
15005800	240	['Immunostaining of Ptch from E13.5 to P 0 confirmed concordance with Shh expression and was not significantly different between wild-type and knockout embryos.']	(29740, 29898)	['GO:0010467', 'PR_EXT:Patched', 'PR_EXT:000014841', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0000922']
15005800	241	['Note that the proximal epithelial cells of primordial tubes were also not immunostained for Ptch at E13.5 lungs (arrows).']	(29899, 30020)	['CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'PR_EXT:Patched', 'UBERON:0000483', 'UBERON:0000025', 'UBERON:0002048']
15005800	242	['Original magnifications: A~F, I and J are 10X.']	(30021, 30067)	[]
15005800	243	['G and H are 20X.']	(30068, 30084)	[]
15005800	244	['To further investigate Shh signaling in these embryos, we examined the patterns of expression of Patched (Ptch), a cognate receptor for Shh and one whose expression is also regulated by Shh signaling.']	(30086, 30286)	['GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO:0010467', 'GO:0010467', 'GO:0065007', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_EXT:0004872', 'PR_EXT:000014841', 'PR_EXT:Patched', 'PR_EXT:Patched', 'PR_EXT:000014841', 'PR_EXT:000014841', 'UBERON:0000922']
15005800	245	['The patterns of Ptch in lung sections from various gestational stages were also indistinguishable between wild-type and knockout embryos (Fig.']	(30287, 30429)	['GO:0007565', 'PR_EXT:Patched', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048', 'UBERON:0000922']
15005800	246	['9, right panels).']	(30430, 30447)	[]
15005800	247	['The expression of Ptch was in concordance with that of Shh (Fig 9, left and right panels), showing lung epithelial cell expression.']	(30448, 30579)	['CL:0000082', 'CL:0000082', 'CL:0000082', 'GO:0010467', 'GO:0010467', 'CL_GO_EXT:cell', 'PR_EXT:Patched', 'PR_EXT:000014841', 'UBERON:0000115', 'UBERON:0000115']
15005800	248	['Downstream of the Shh-Ptch signaling cascade are proteins such as smoothened (Smo), and Gli proteins, key regulators of target-gene expression in response to Shh signaling.']	(30580, 30752)	['CHEBI_PR_EXT:protein', 'CHEBI_PR_EXT:protein', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_EXT:regulator', 'GO:0010467', 'GO:0010467', 'GO_EXT:reaction_or_response', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'PR_EXT:000014841', 'PR_EXT:Patched', 'CHEBI_PR_EXT:protein', 'PR_EXT:000015288', 'PR_EXT:000015288', 'PR_EXT:Gli', 'CHEBI_PR_EXT:protein', 'PR_EXT:000014841', 'SO_EXT:0000704']
15005800	249	['No differences in expression patterns for Smo (Fig.']	(30753, 30804)	['GO:0010467', 'PR_EXT:000015288']
15005800	250	['10, upper panels), Gli1 (Fig.']	(30805, 30834)	['PR_EXT:000008026']
15005800	251	['10, middle panels) or Gli3 (Fig.']	(30835, 30867)	['PR_EXT:000008028']
15005800	252	['10, bottom panels) were noted between wild-type and knockout lungs at E13.5, E15.5 and E17.5 gestational days.']	(30868, 30978)	['GO:0007565', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048']
15005800	253	['Figure 10\n\nComparisons of Smo, Gli1 and Gli3 expression in lung sections.']	(30980, 31053)	['GO:0010467', 'PR_EXT:000015288', 'PR_EXT:000008026', 'PR_EXT:000008028', 'UBERON:0002048']
15005800	254	['Smoothened (Smo, upper panel), Gli1 (middle panel) and Gli3 (bottom panel) showed a pattern of distribution similar to that seen with Shh and Ptch (compare to Fig.']	(31054, 31217)	['PR_EXT:000015288', 'PR_EXT:000015288', 'PR_EXT:000008026', 'PR_EXT:000008028', 'PR_EXT:000014841', 'PR_EXT:Patched']
15005800	255	['7).']	(31218, 31221)	[]
15005800	256	['No differences between wild-type (+/+) and knockout (-/-) embryos were evident.']	(31222, 31301)	['SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922']
15005800	257	['Original magnifications: 20X.']	(31302, 31331)	[]
15005800	258	['Shh protein processing in Dhcr7-/- embryos\n\nSince Shh expression, as well as some of the Shh signaling components appeared to be normal in Dhcr7-/- embryos, endogenous autoprocessing of Shh to generate a cholesterol-modified N-terminal fragment of Shh (Shh-Np) was evaluated.']	(31333, 31608)	['CHEBI_PR_EXT:protein', 'CHEBI:16113', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'GO:0016485', 'GO:0016485', 'GO:0010467', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO:0016540', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'CHEBI_PR_EXT:protein', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'PR_EXT:000014841', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'PR_EXT:000014841', 'PR_EXT:000014841', 'SO_EXT:sequence_alteration_process', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_alteration_process', 'SO_EXT:sequence_alteration_process', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'UBERON:0000922', 'UBERON:0000922']
15005800	259	['COS-1 cells, transfected with full length Shh cDNA (capable of endogenous autocleavage) or a truncated Shh cDNA (Shh-N, expression of the shorter form constitutively) were used as controls (Fig.']	(31609, 31803)	['CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CL_GO_EXT:cell', 'GO:0009294', 'GO:0010467', 'CL_GO_EXT:cell', 'PR_EXT:000014841', 'PR_EXT:000014841', 'PR_EXT:000014841', 'SO_EXT:cDNA', 'SO_EXT:sequence_truncation_process', 'SO_EXT:cDNA', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region']
15005800	260	['11, tracks 1 and 2).']	(31804, 31824)	[]
15005800	261	['Transfection of the full-length cDNA for Shh led to the detection of an ~20 kD protein that corresponds with the cleaved and tailed Shh (Fig.']	(31825, 31966)	['CHEBI_PR_EXT:protein', 'GO:0009294', 'MOP:0000780', 'PR_EXT:000014841', 'CHEBI_PR_EXT:protein', 'PR_EXT:000014841', 'SO_EXT:cDNA']
15005800	262	['11, track 1), as previously described [35].']	(31967, 32010)	[]
15005800	263	['Transfection of COS cells with the constitutive truncated Shh-N cDNA led to two slower migrating bands that correspond to truncated Shh, but which are thought to be generated by differences in lipid modifications, as previously demonstrated [35].']	(32011, 32257)	['CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI:18059', 'CL_GO_EXT:cell', 'GO:0009294', 'GO_EXT:biological_movement_or_translocation_process', 'CL_GO_EXT:cell', 'PR_EXT:000014841', 'PR_EXT:000014841', 'SO_EXT:sequence_truncation_process', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'SO_EXT:cDNA', 'SO_EXT:sequence_truncation_process', 'SO_EXT:sequence_alteration_entity_or_process']
15005800	264	['In tissue lysates from wild-type, Dhcr7+/- and Dhcr7-/- embryos at E11.5, a band running at the same position as Shh-Np (autocleaved and tailed) was detected in all of the lysates.']	(32258, 32438)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000479', 'UBERON:0000922']
15005800	265	['There were no distinguishable differences between Dhcr7-/- and the wild-type samples, suggesting that Shh autoprocessing occurred normally, despite an absolute deficiency of cholesterol in knockout embryos.']	(32439, 32645)	['CHEBI:16113', 'GO:0016540', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:sequence_alteration_process', 'UBERON:0000922']
15005800	266	['More importantly, no band corresponding to a full-length Shh (~45 kD) was present in the lung lysates from the knockout embryos, suggesting that processing of Shh was not impaired.']	(32646, 32826)	['PR_EXT:000021466', 'PR_EXT:000021466', 'PR_EXT:000021466', 'PR_EXT:000021466', 'PR_EXT:000014841', 'SO_EXT:sequence_alteration_process', 'UBERON:0002048', 'UBERON:0000922']
15005800	267	['Figure 11\n\nShh protein autoprocessing in mouse embryos.']	(32828, 32883)	['CHEBI_PR_EXT:protein', 'GO:0016540', 'GO:0016540', 'NCBITaxon:10088', 'PR_EXT:000014841', 'CHEBI_PR_EXT:protein', 'SO_EXT:sequence_alteration_process', 'UBERON:0000922']
15005800	268	['Western blotting of lysates from wild-type (track 3), heterozygous (track 4) and knockout (track 5) embryos at E11.5, or COS1 cells transfected with Shh (track 1) or Shh-N (track 2) were probed with anti-Shh-N19 antibodies.']	(32884, 33107)	['CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CL_GO_EXT:cell', 'GO:0009294', 'CL_GO_EXT:cell', 'GO:0042571', 'PR_EXT:000014841', 'PR_EXT:000014841', 'PR_EXT:000014841', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'UBERON:0000922']
15005800	269	['20 μ g of lysate proteins from Shh transfected COS1 cells and 75 μ g from embryos was loaded.']	(33108, 33201)	['CHEBI_PR_EXT:protein', 'CL_GO_EXT:cell', 'GO:0009294', 'CL_GO_EXT:cell', 'CHEBI_PR_EXT:protein', 'PR_EXT:000014841', 'UBERON:0000922']
15005800	270	['Both unprocessed (Shh, upper arrow ~45 kDa, faint signal) and processed (Shh-Np, lowest arrow, strong signal, track 1) forms of Shh were detected from Shh transfected COS1 cells.']	(33202, 33380)	['CL_GO_EXT:cell', 'GO:0009294', 'CL_GO_EXT:cell', 'PR_EXT:000014841', 'PR_EXT:000014841', 'PR_EXT:000014841', 'PR_EXT:000014841', 'SO_EXT:sequence_alteration_process', 'SO_EXT:sequence_alteration_process']
15005800	271	['The two slower migrating bands in Shh-N transfected COS1 cells (track 2) represented Shh-N proteins with different lipid modifications at its N terminus.']	(33381, 33534)	['CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_PR_EXT:protein', 'CHEBI:18059', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CL_GO_EXT:cell', 'GO_EXT:biological_movement_or_translocation_process', 'GO:0009294', 'CL_GO_EXT:cell', 'PR_EXT:000014841', 'PR_EXT:000014841', 'CHEBI_PR_EXT:protein', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'SO_EXT:sequence_alteration_entity_or_process', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region']
15005800	272	['A major band running at the same position as processed Shh was detected in lysates from all the embryos (tracks 3–5).']	(33535, 33652)	['PR_EXT:000014841', 'SO_EXT:sequence_alteration_process', 'UBERON:0000922']
15005800	273	['Importantly, no significant amounts of unprocessed or aberrantly migrating Shh proteins were detected in lysates from knockout embryos at this stage.']	(33653, 33802)	['CHEBI_PR_EXT:protein', 'GO_EXT:biological_movement_or_translocation_process', 'PR_EXT:000014841', 'CHEBI_PR_EXT:protein', 'SO_EXT:sequence_alteration_process', 'UBERON:0000922']
15005800	274	['Discussion\n\nThe elucidation that SLOS is caused by a defect in an enzyme necessary for cholesterol biosynthesis has improved our understanding of embryonic development.']	(33804, 33972)	['CHEBI_GO_SO_EXT:enzyme', 'CHEBI:16113', 'GO:0006695', 'GO:0006695', 'GO:0009790', 'GO:0009790', 'CHEBI_GO_SO_EXT:enzyme', 'CHEBI_GO_SO_EXT:enzyme', 'UBERON:0000922']
15005800	275	['This discovery has led to the identification of other disorders of embryonic development caused by mutations in genes encoding other enzymes in the post-squalene steps of cholesterol biosynthesis.']	(33973, 34169)	['CHEBI_GO_SO_EXT:enzyme', 'CHEBI:15440', 'CHEBI:16113', 'GO:0009790', 'GO:0009790', 'GO:0006695', 'GO:0006695', 'CHEBI_GO_SO_EXT:enzyme', 'SO_EXT:sequence_alteration_entity_or_process', 'SO_EXT:0000704', 'SO_EXT:sequence_coding_function', 'CHEBI_GO_SO_EXT:enzyme', 'UBERON:0000922']
15005800	276	['Although these genetic studies now implicate the need for normal cholesterol synthesis, the mechanistic role(s) of cholesterol in normal embryonic development remains to be clarified.']	(34170, 34353)	['CHEBI:16113', 'CHEBI:16113', 'GO:0006695', 'GO:0006695', 'GO:0009790', 'GO:0009790', 'SO_EXT:0000704', 'UBERON:0000922']
15005800	277	['In the present study, we report the characterization of lung development in Dhcr7-/- embryos.']	(34355, 34448)	['GO:0030324', 'GO:0030324', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0000922']
15005800	278	['Although cardiac abnormalities are common in human SLOS [36], no structural abnormalities of the heart or the great vessels were observed in the Dhcr7-/- pups.']	(34449, 34608)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:9606', 'NCBITaxon_UBERON_EXT:pup', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000948', 'UBERON:0000948', 'UBERON:0013768', 'UBERON:0013768', 'NCBITaxon_UBERON_EXT:pup']
15005800	279	['Lung development in Dhcr7-/- embryos at the early stages, from lung bud formation to canalicular stage, was morphologically similar to controls.']	(34609, 34753)	['GO:0030324', 'GO:0030324', 'GO:0060431', 'GO:0060431', 'GO:0060431', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0000922', 'UBERON:0000118', 'UBERON:0000118']
15005800	280	['Instead, a distinct lung hypoplasia at the saccular stage, characterized by arrested or partially developed distal epithelial tubules, reduced terminal sac space, delayed type I AECs differentiation and delayed vascular development, was consistently observed at late gestational stages in Dhcr7-/- embryos.']	(34754, 35060)	['CL:0002062', 'CL:0002062', 'CL:0002062', 'GO_RO_EXT:developmental_differentiation_process', 'GO:0007565', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0000116', 'UBERON:0003914', 'UBERON:0003914', 'UBERON:0009856', 'UBERON_EXT:vascular_system_or_vasculature_or_vessel', 'UBERON:0000922']
15005800	281	['At late stages of normal fetal development, the mammalian alveolar epithelium undergoes an abrupt differentiation as a part of the preparation of the lungs for the postnatal demands of gas exchange [37].']	(35061, 35264)	['GO_RO_EXT:developmental_differentiation_process', 'GO:0007567', 'GO:0007585', 'GO:0007585', 'NCBITaxon:40674', 'UBERON:0004821', 'UBERON:0004821', 'UBERON:0002048']
15005800	282	['Both type II AECs, producing pulmonary surfactants, and type I AECs, lining the expanded alveoli, are important for alveolar maturation.']	(35265, 35401)	['CHEBI_EXT:35195', 'CL:0002063', 'CL:0002063', 'CL:0002063', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'GO_PATO_EXT:biological_maturation', 'UBERON:0002048', 'UBERON:0003215', 'UBERON:0003215']
15005800	283	['In addition, the vascular development of alveoli is also essential for normal lung morphogenesis at late gestational stages [19].']	(35402, 35531)	['GO:0048286', 'GO:0048286', 'GO:0048286', 'GO:0060425', 'GO:0060425', 'GO:0007565', 'UBERON_EXT:vascular_system_or_vasculature_or_vessel', 'UBERON:0003215', 'UBERON:0002048']
15005800	284	['We show here that the differentiation of type I AECs but not type II AECs in Dhcr7-/- lungs was blocked or delayed, as indicated by fewer flattened type I cells and by reduced expression of markers of type I AECs, T1α and AQP5.']	(35532, 35759)	['CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002063', 'CL:0002063', 'CL:0002063', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'CL:0002062', 'GO_RO_EXT:developmental_differentiation_process', 'GO:0010467', 'CL_GO_EXT:cell', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000012516', 'PR_EXT:000004185', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'UBERON:0002048']
15005800	285	['Delayed vascular development was also involved in the delayed sacculation of Dhcr7-/- lungs.']	(35760, 35852)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON_EXT:vascular_system_or_vasculature_or_vessel', 'UBERON:0002048']
15005800	286	['Additionally, the mesenchyme separating the AECs from the vascular beds remained thickened.']	(35853, 35944)	['CL:0010003', 'UBERON:0003104', 'UBERON:0002049', 'UBERON:0002049']
15005800	287	['In support of normal differentiation of type II AECs, no alteration in the gene expression patterns for surfactant proteins A, B, C or D was noted, nor was the pattern of distribution of SP-C altered in lungs from knockout embryos.']	(35945, 36176)	['CHEBI_EXT:35195', 'CHEBI_PR_EXT:protein', 'CL:0002063', 'CL:0002063', 'CL:0002063', 'GO_RO_EXT:developmental_differentiation_process', 'GO:0010467', 'GO:0010467', 'PR_EXT:000015945', 'PR_EXT:000014773', 'PR_EXT:000014774', 'PR_EXT:000014775', 'PR_EXT:000015945', 'PR_EXT:000014773', 'PR_EXT:000014774', 'PR_EXT:000014775', 'PR_EXT:000015945', 'PR_EXT:000014773', 'PR_EXT:000014774', 'PR_EXT:000014775', 'PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014774', 'SO_EXT:0000704', 'UBERON:0002048', 'UBERON:0000922']
15005800	288	['Thus, impaired gas exchange, as opposed to poor inflation and alveolar tension, may be the cause of respiratory failure in these pups.']	(36177, 36311)	['GO:0007585', 'GO:0007585', 'NCBITaxon_UBERON_EXT:pup', 'UBERON:0003215', 'UBERON:0001004', 'NCBITaxon_UBERON_EXT:pup']
15005800	289	['Loss of functional Dhcr7 led to a retardation of embryonic growth from E14.5~E16.5 onwards.']	(36313, 36404)	['GO_EXT:biological_growth_entity_or_process', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'UBERON:0000922']
15005800	290	['By this stage, cholesterol levels were already lower and its immediate precursor, 7-DHC, elevated in the lungs (this study) as well as in the whole body [16,17].']	(36405, 36566)	['CHEBI:16113', 'CHEBI:17759', 'CHEBI:17759', 'CHEBI:17759', 'UBERON:0002048', 'UBERON:0000468', 'UBERON:0000468']
15005800	291	['Intrauterine growth retardation (IUGR) followed by postnatal failure to thrive is a universally observed phenotype in SLOS patients [2,18].']	(36567, 36706)	['GO_EXT:biological_growth_entity_or_process', 'GO:0007567', 'UBERON:0000995']
15005800	292	['We showed here that body length was significantly reduced at later stages of gestation in Dhcr7-/- animals, compared to controls.']	(36707, 36836)	['GO:0007565', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:33208', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON_EXT:body']
15005800	293	['Whole body weights and fresh lung weights (as well as brain, heart and kidney, data not shown) at late gestational stages were also lower in Dhcr7-/- embryos.']	(36837, 36995)	['GO:0007565', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000468', 'UBERON:0000468', 'UBERON:0002048', 'UBERON:0000955', 'UBERON:0000948', 'UBERON:0002113', 'UBERON:0000922']
15005800	294	['Interestingly, the lower lung/body ratios at E18.5 in Dhcr7-/- embryos compared to wild-type suggested a disproportionate inhibition of lung growth than other organs.']	(36996, 37162)	['GO_EXT:biological_growth_entity_or_process', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0002048', 'UBERON_EXT:body', 'UBERON:0000922', 'UBERON:0002048', 'UBERON:0000062']
15005800	295	['Cell proliferation and division in Dhcr7-/- lungs were markedly arrested without apparent increase in cell apoptosis.']	(37163, 37280)	['CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO:0051301', 'GO:0008283', 'GO:0008283', 'GO:0051301', 'GO:0006915', 'GO:0006915', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048']
15005800	296	['Therefore, it appears that growth retardation caused by cholesterol deficiency was primarily because of an inhibition of cell growth and proliferation, rather than an increase in cell death.']	(37281, 37471)	['CHEBI:16113', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO_EXT:biological_growth_entity_or_process', 'GO:0008283', 'GO_EXT:biological_growth_entity_or_process', 'GO:0008283', 'GO:0008219', 'GO:0008219', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell']
15005800	297	['Cholesterol is present in Dhcr7-/- embryos, as it is in Sc5d-/- (lathosterolosis) and Dhcr24-/-(desmosterolosis) embryos [15,38].']	(37473, 37602)	['CHEBI:16113', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014480', 'PR_EXT:000006453', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922', 'UBERON:0000922']
15005800	298	['Total sterols and cholesterol in Dhcr7-/- embryonic lungs (as well as in brain and liver, data not shown) were reduced and 7DHC/8DHC elevated, but a significant amount of cholesterol was detectable, comprising ~60% and ~30% of total tissue sterols at E13.5 and neonate, respectively.']	(37603, 37886)	['CHEBI:15889', 'CHEBI:16113', 'CHEBI:17759', 'CHEBI:16113', 'CHEBI:15889', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922', 'UBERON:0002048', 'UBERON:0000955', 'UBERON:0002107', 'UBERON:0000479', 'PATO_UBERON_EXT:neonate_or_newborn']
15005800	299	['Fetal cholesterol can either be synthesized endogenously in fetal tissues or accrued from extra-embryonic tissues such as maternal serum, placenta, and yolk sac [39].']	(37887, 38053)	['CHEBI:16113', 'UBERON:0005291', 'UBERON:0005291', 'UBERON:0005292', 'UBERON:0005292', 'UBERON:0005292', 'UBERON:0005292', 'UBERON:0001977', 'UBERON:0001987', 'UBERON:0001040', 'UBERON:0001040']
15005800	300	['Since these mice theoretically can not synthesize cholesterol, any accumulation of cholesterol must be derived from the maternal sources.']	(38054, 38191)	['CHEBI:16113', 'CHEBI:16113', 'NCBITaxon:10088']
15005800	301	['Interestingly, Dhcr24 null mice are viable but contained almost no cholesterol in plasma and tissues at 3-months, whereas cholesterol content in Dhcr24 null embryo tissues accounts for ~60% at E11.5 and ~30% at E17.5, of total tissue sterols [38].']	(38192, 38439)	['CHEBI:16113', 'CHEBI:16113', 'CHEBI:15889', 'NCBITaxon:10088', 'PR_EXT:000006453', 'PR_EXT:000006453', 'SO_EXT:sequence_nullness', 'SO_EXT:sequence_nullness', 'UBERON:0001969', 'UBERON:0000479', 'UBERON:0005291', 'UBERON:0005291', 'UBERON:0000479']
15005800	302	['These results, as well as this study, suggest that a considerable amount of maternal cholesterol can be transferred to the murine fetus.']	(38440, 38576)	['CHEBI:16113', 'GO_EXT:biological_movement_or_translocation_process', 'NCBITaxon:39107']
15005800	303	['One explanation of why the Dhcr24-/- mice are developmentally normal but Dhcr7-/- mice are affected may be because desmosterol can functionally substitute for cholesterol, whereas the other cholesterol precursors can not.']	(38577, 38798)	['CHEBI:17737', 'CHEBI:16113', 'CHEBI:16113', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000006453', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence']
15005800	304	['Although a mechanistic understanding of why a deficiency in cholesterol biosynthesis leads to abnormal embryonic development is lacking, a frequently advanced explanation has been that Shh signaling, involved in early developmental patterning, may be disrupted.']	(38800, 39061)	['CHEBI:16113', 'GO:0006695', 'GO:0006695', 'GO:0009790', 'GO:0009790', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_PATO_EXT:biological_patterning_process_or_quality', 'PR_EXT:000014841', 'UBERON:0000922']
15005800	305	['In the developing lung primordium, Shh is expressed initially at E9 and promotes branching morphogenesis, which is impaired in Shh knockout mice [24], suggesting that Shh, secreted by the epithelium, is critical for branching morphogenesis.']	(39062, 39302)	['GO:0010467', 'GO:0001763', 'GO:0001763', 'GO:0046903', 'GO:0001763', 'GO:0001763', 'NCBITaxon:10088', 'PR_EXT:000014841', 'PR_EXT:000014841', 'PR_EXT:000014841', 'UBERON:0005597', 'UBERON:0005597', 'UBERON:0000483']
15005800	306	['In this study, the lack of evidence of abnormal lung branching morphogenesis in the early stages, but a consistent delayed maturation of the gas-exchange region of the lung in the saccular period of development of Dhcr7-/- embryos was observed, suggesting early Shh signaling was normal.']	(39303, 39590)	['GO:0060441', 'GO:0060441', 'GO:0060441', 'GO_PATO_EXT:biological_maturation', 'GO:0007585', 'GO:0007585', 'GO:0007585', 'GO:0009790', 'GO:0009790', 'GO:0009790', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0002048', 'UBERON:0002048', 'UBERON:0000116', 'UBERON:0000922']
15005800	307	['Shh protein expression and autoprocessing at E11.5 was indistinguishable between wild-type and Dhcr7-/- embryos.']	(39591, 39703)	['CHEBI_PR_EXT:protein', 'GO:0016540', 'GO:0010467', 'GO:0016540', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'CHEBI_PR_EXT:protein', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_alteration_process', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922']
15005800	308	['Additionally, although these experiments were not quantitative, the abundance of Shh appeared unchanged between these genotypes.']	(39704, 39832)	['PR_EXT:000014841', 'SO_EXT:genotype_or_entity_with_genotype']
15005800	309	['Thus, it is possible that the cholesterol levels (roughly 50% of normal levels) in Dhcr7-/- embryos were enough for completion of Shh autoprocessing or 7DHC accumulated in Dhcr7-/- embryonic tissues can also participate efficiently as a sterol adduct in the Shh processing reaction [20].']	(39833, 40120)	['CHEBI:16113', 'CHEBI:17759', 'CHEBI:15889', 'GO:0016540', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_alteration_process', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_alteration_process', 'UBERON:0000922', 'UBERON:0005291', 'UBERON:0005291']
15005800	310	['In this study, we also examined the Shh signaling pathway by immunohistochemistry of known key components of this pathway, such as patched, smoothened and Gli proteins.']	(40121, 40289)	['CHEBI_PR_EXT:protein', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'PR_EXT:000014841', 'PR_EXT:Patched', 'PR_EXT:000015288', 'PR_EXT:Gli', 'CHEBI_PR_EXT:protein']
15005800	311	['Shh signaling leads to the activation of transcription and increased protein levels of these components [40-42].']	(40290, 40402)	['CHEBI_PR_EXT:protein', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_EXT:transcription', 'PR_EXT:000014841', 'CHEBI_PR_EXT:protein']
15005800	312	['If Shh signaling were defective in Dhcr7-/- embryos, these could have resulted in abnormalities of the staining patterns of these components, but no such disturbance was detected.']	(40403, 40582)	['GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0000922']
15005800	313	['Indeed, the patterns of protein expression seemed comparable and indistinguishable from wild-type embryos at all stages of lung development examined.']	(40583, 40732)	['CHEBI_PR_EXT:protein', 'GO:0010467', 'GO:0030324', 'GO:0030324', 'CHEBI_PR_EXT:protein', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'UBERON:0000922', 'UBERON:0002048']
15005800	314	['In a recent in vitro study [43], mouse embryonic fibroblasts (MEFs) from Dhcr7-/- embryos, grown in lipid-depleted culture and transiently treated with cyclodextrin, showed no affect on Shh processing.']	(40734, 40935)	['CHEBI:18059', 'CHEBI:23456', 'CL:0000057', 'GO:0040007', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_alteration_process', 'UBERON:0000922', 'UBERON:0000922']
15005800	315	['However, a deficiency in their ability to respond to Shh activation, as judged by reporter gene expression, was demonstrable.']	(40936, 41061)	['GO_EXT:reaction_or_response', 'GO:0010467', 'GO:0010467', 'PR_EXT:000014841', 'SO_EXT:0000704']
15005800	316	['In contrast, when CHO cells, that stably expressed Shh, were subjected to sterol deprivation, an arrest of Shh autoprocessing was clearly demonstrable [29].']	(41062, 41218)	['CHEBI:15889', 'CL_GO_EXT:cell', 'GO:0010467', 'GO:0016540', 'CL_GO_EXT:cell', 'PR_EXT:000014841', 'PR_EXT:000014841', 'SO_EXT:sequence_alteration_process']
15005800	317	['In the present study, we did not detect unprocessed Shh in Dhcr7-/- embryonic tissues at E11.5.']	(41219, 41314)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'PR_EXT:000014841', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_alteration_process', 'SO_EXT:sequence_nullness_or_absence', 'SO_EXT:sequence_nullness_or_absence', 'UBERON:0005291', 'UBERON:0005291']
15005800	318	['Subtle differences in Shh signal transduction can not be excluded by the present study.']	(41315, 41402)	['GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'PR_EXT:000014841']
15005800	319	['However, we favor a model whereby the loss of normal cholesterol biosynthesis is important, not so much for Shh autocleavage, as for the loss of the correct plasma membrane milieu.']	(41403, 41583)	['CHEBI:16113', 'GO:0006695', 'GO:0006695', 'GO:0005886', 'GO:0005886', 'PR_EXT:000014841']
15005800	320	['Since the loss of cholesterol content in the plasma membrane (and perhaps any membrane) is likely to alter the function of receptors more sensitive to this, loss of normal cholesterol synthesis may cause a loss of signal transduction of a host of such pathways.']	(41584, 41845)	['CHEBI:16113', 'CHEBI:16113', 'GO:0006695', 'GO:0006695', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO:0005886', 'GO:0005886', 'GO:0016020', 'GO_EXT:0004872']
15005800	321	['Thus, this effect may not be limited to the Shh pathway and other targets may be more important.']	(41846, 41942)	['PR_EXT:000014841']
15005800	322	['This hypothesis is amenable to testing in the Dhcr7 null mice.']	(41943, 42005)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:sequence_nullness']
15005800	323	['Conclusion\n\nCholesterol deficiency caused by Dhcr7 deficiency in mice resulted in, along with IUGR, a distinct lung saccular hypoplasia with impaired differentiation of type I but not type II AECs and delayed associated vascular development.']	(42007, 42248)	['CHEBI:16113', 'CL:0002062', 'CL:0002062', 'CL:0002063', 'CL:0002063', 'CL:0002062', 'CL:0002063', 'GO_RO_EXT:developmental_differentiation_process', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:10088', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'UBERON:0000116', 'UBERON:0000116', 'UBERON_EXT:vascular_system_or_vasculature_or_vessel']
15005800	324	['Loss of the correct amounts of cholesterol in the membranes may perturb those receptors that depend upon cholesterol for efficient signal transduction.']	(42249, 42400)	['CHEBI:16113', 'CHEBI:16113', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO:0016020', 'GO_EXT:0004872']
15005800	325	['Further investigation of which transcriptional and signal transduction pathways are more significantly affected by the loss of Dhcr7 will be critical to elucidate the mechanism of lung hypoplasia of this model, as well as the role of cholesterol in embryonic development.']	(42401, 42672)	['CHEBI:16113', 'GO_EXT:transcription', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO:0009790', 'GO:0009790', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'UBERON:0002048', 'UBERON:0000922']
15005800	326	['Methods\n\nAnimals\n\nAll mice were housed in an animal facility at 22°C with a 12 h light ~12 h dark cycle and all protocols were approved by the Institutional Animal Welfare Committee.']	(42674, 42856)	['NCBITaxon:33208', 'NCBITaxon:10088', 'NCBITaxon:33208', 'NCBITaxon:33208']
15005800	327	['Dhcr7 heterozygous animals used in this study have been backcrossed onto a C57BL/6J background for 11 successive generations.']	(42857, 42982)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'NCBITaxon:33208', 'GO_PR_EXT:7_dehydrocholesterol_reductase']
15005800	328	['The presence of vaginal plugs was considered as embryonic day (E) 0.5.']	(42983, 43053)	['UBERON:0010148', 'UBERON:0010148', 'UBERON:0000922']
15005800	329	['Timed pregnant females were sacrificed, embryos dissected from the uteri and placed in 1X PBS.']	(43054, 43148)	['GO:0007565', 'GO_EXT:killing', 'PATO_UBERON_EXT:female_or_bearer_of_femaleness', 'UBERON:0000922', 'UBERON:0000995']
15005800	330	['Crown-rump lengths of the embryos were measured by use of an electronic digital caliper and embryos weighed, after blotting off excess fluid.']	(43149, 43290)	['UBERON:0000033', 'UBERON:0013691', 'UBERON:0000922', 'UBERON:0000922', 'UBERON:0006314']
15005800	331	['Each lung was removed intact from the thoracic cavity, blotted free of excess fluid, and weighed.']	(43291, 43388)	['UBERON:0002048', 'UBERON:0002224', 'UBERON:0002224', 'UBERON:0006314']
15005800	332	['Mice were classified as P0 when birth was witnessed and their breathing activities visualized under a dissecting microscope.']	(43389, 43513)	['GO:0007567', 'NCBITaxon:10088']
15005800	333	['Digital images of embryos or lungs were captured using a Zeiss-1000 dissecting microscope.']	(43514, 43604)	['UBERON:0000922', 'UBERON:0002048']
15005800	334	['Genotyping was performed by PCR, as described previously [16].']	(43605, 43667)	[]
15005800	335	['And in selective cases, Southern blotting was performed for confirmation of Dhcr7 genotype.']	(43668, 43759)	['GO_PR_EXT:7_dehydrocholesterol_reductase', 'GO_PR_EXT:7_dehydrocholesterol_reductase', 'SO_EXT:genotype_or_entity_with_genotype']
15005800	336	['Biochemical measurements\n\nTissue sterol compositions were analyzed by gas chromatography-mass spectrometry (GC-MS) as described previously [2,44].']	(43761, 43907)	['CHEBI_EXT:biochemical', 'CHEBI:15889', 'UBERON:0000479']
15005800	337	['Serum corticosterone levels were measured by radioimmunoassay (RIA) on the blood obtained from decapitated neonates by a commercial source (DRTC hormone Assay Core Lab, Vanderbilt University, TN).']	(43908, 44104)	['CHEBI:16827', 'CHEBI_GO_EXT:hormone', 'CHEBI_GO_EXT:hormone', 'UBERON:0001977', 'UBERON:0000178', 'PATO_UBERON_EXT:neonate_or_newborn']
15005800	338	["Histology and Immunohistochemistry\n\nThoracic parts from embryos or P0 mice were fixed in either Amsterdam's fixative (methanol:acetone:acetic acid:water, 35:35:5:25 v/v) or 4% paraformaldehyde in PBS."]	(44106, 44306)	['CHEBI_EXT:50913', 'CHEBI:17790', 'CHEBI:15347', 'CHEBI:15366', 'CHEBI:15366', 'CHEBI:15377', 'CHEBI_EXT:paraformaldehye', 'NCBITaxon:10088', 'UBERON:0000915', 'UBERON:0000922']
15005800	339	['Tissues were fixed overnight at room temperature (RT), rinsed in PBS, dehydrated in a graded ethanol series, cleared in toluene and embedded in paraffin.']	(44307, 44460)	['CHEBI:16236', 'CHEBI:17578', 'UBERON:0000479']
15005800	340	['Five μ m sections were mounted on Superfrost-Plus slides (VWR, West Chester, PA) for histological or immunohistochemistry (IHC) analyses.']	(44461, 44598)	[]
15005800	341	['IHC was performed using an indirect method.']	(44600, 44643)	[]
15005800	342	['After deparaffination in xylene and rehydration through a graded series of ethanol, sections were heated at 95°C in 10 mM sodium citrate (pH 6.0) for an initial 15 min and for three successive 5-min periods [25].']	(44644, 44856)	['CHEBI:27338', 'CHEBI:16236', 'CHEBI:53258', 'CHEBI:53258']
15005800	343	['After cooling, the sections were treated with hydrogen peroxide (3% v/v in PBS, pH7.4) for 10 min and rinsed in the PBS.']	(44857, 44977)	['CHEBI:16240', 'CHEBI:16240']
15005800	344	['Sections were blocked with 5% normal serum for 2 h, washed in PBS and incubated with antibodies against Shh-N19 (1:100), Patched (1:100), Smo-N19 (1:100), Gli1 (1:100), Gli3-N19 (1:100), SP-C C19 (1:200), caveolin 1α-N20 (1:200), aquaporin 5 (AQP5, 1:200), megalin (1:200), PECAM-1 (1:200) (Santa Cruz Biotechnology, Santa Cruz, CA) or T1α (mAB 8.1.1, 1:1000 dilution, Developmental Studies Hybridoma Bank, Iowa City, IA) overnight at 4° C in a humidified chamber.']	(44978, 45442)	['GO:0042571', 'PR_EXT:000014841', 'PR_EXT:Patched', 'PR_EXT:000015288', 'PR_EXT:000008026', 'PR_EXT:000008028', 'PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000027209', 'PR_EXT:000027209', 'PR_EXT:000004185', 'PR_EXT:000004185', 'PR_EXT:000004185', 'PR_EXT:000009921', 'PR_EXT:000001904', 'PR_EXT:000001904', 'PR_EXT:000001904', 'PR_EXT:000012516', 'UBERON:0001977']
15005800	345	['The sections were washed in PBS, incubated with biotinylated secondary antibodies (1:1000~1:5000, Santa Cruz Biotechnology) in PBS for 2 h at RT, incubated with HRP-streptavidin complex for 30 min, rinsed in PBS and visualized using a Metal Enhanced Diaminobenzidine (DAB) Substrate Kit (Pierce, Rockford, IL).']	(45443, 45753)	['CHEBI_EXT:metal', 'GO:0042571', 'GO:0032991', 'MOP:0000093']
15005800	346	['Digital images were collected using a Polaroid Digital Microscope Camera mounted on an Olympus BX40 microscope.']	(45754, 45865)	[]
15005800	347	['Lung morphometry\n\nTerminal saccular space areas were measured using NIH Image software (NIH, Bethesda, MD) as previously described [45].']	(45867, 46003)	['UBERON:0002048', 'UBERON:0000116']
15005800	348	['Multiple measurements were performed on randomly selected 0.04-mm2 fields located in the distal part of the lung sections.']	(46004, 46126)	['UBERON:0002048']
15005800	349	['The proportion of lung comprising terminal saccular spaces was calculated as a percentage of the total examined area of the lung section.']	(46127, 46264)	['UBERON:0002048', 'UBERON:0000116', 'UBERON:0002048']
15005800	350	['Three animals per genotype were examined.']	(46265, 46306)	['NCBITaxon:33208', 'SO_EXT:genotype_or_entity_with_genotype']
15005800	351	['Assessment of cell proliferation/Division/death\n\nChanges in cell proliferation and division were assessed by proliferating cell nuclear antigen (PCNA) IHC, bromodeoxyuridine (BrdU) incorporation and phosphorylated histone H3 (pHH3) IHC.']	(46308, 46544)	['CHEBI_EXT:59132', 'CHEBI:472552', 'CHEBI:472552', 'CHEBI:15358', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO:0008219', 'GO:0051301', 'GO:0008283', 'GO:0008283', 'GO:0051301', 'GO:0008219', 'GO:0051301', 'GO:0008283', 'GO:0008283', 'GO:0051301', 'GO:0008283', 'GO_PATO_EXT:phosphorylation_process_or_quality', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000012421', 'PR_EXT:000012421', 'PR_EXT:000012421', 'PR_EXT:000012421', 'PR_EXT:000012421', 'PR_EXT:000027594', 'PR_EXT:000027594']
15005800	352	['The PCNA (1:2000) and pHH3-Ser28 (1:200) antibodies were obtained from Santa Cruz Biotechnology.']	(46545, 46641)	['GO:0042571', 'PR_EXT:000012421']
15005800	353	['For BrdU incorporation, timed pregnant mice at E18.5 were injected intra-peritoneally with 100 μg/gm body weight of BrdU (Sigma, St Louis, MO) 2 h prior to sacrifice, embryos dissected from uteri and processed as described above.']	(46642, 46871)	['CHEBI:472552', 'CHEBI:472552', 'GO:0007565', 'GO_EXT:killing', 'NCBITaxon:10088', 'UBERON:0001179', 'UBERON_EXT:body', 'UBERON:0000922', 'UBERON:0000995']
15005800	354	['Sections were stained with a monoclonal anti-BrdU antibody (1:100, Developmental Studies Hybridoma Bank, Iowa City, IA) and visualized with a Cy2-conjugated rabbit anti-mouse antibody using a laser-scanning confocal microscope.']	(46872, 47099)	['CHEBI:472552', 'CHEBI:52302', 'GO:0042571', 'GO:0042571', 'MOP:0000779', 'NCBITaxon:9986', 'NCBITaxon:10088']
15005800	355	["Cell death was investigated by terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling (TUNEL) using the Fluorescein In Situ Cell Death Detection Kit (Roche, Indianapolis, IN) according to the manufacturer's protocol."]	(47100, 47330)	['CHEBI_EXT:dUTP', 'CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process', 'CHEBI:31624', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO:0008219', 'GO:0008219', 'GO:0008219', 'GO:0008219', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO_PR_EXT:DNA_nucleotidylexotransferase', 'GO_PR_EXT:DNA_nucleotidylexotransferase', 'GO_PR_EXT:DNA_nucleotidylexotransferase', 'GO_PR_EXT:DNA_nucleotidylexotransferase', 'CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process']
15005800	356	['Western blotting\n\nSample preparation and western blotting was performed according to Kawakami et al with some minor modifications [35].']	(47332, 47467)	[]
15005800	357	['Briefly, 3 embryos from each genotype were pooled, homogenized in ice cold lysis buffer (50 mM Tris-pH8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.5 mM DTT, 1 mM PMSF and 2 μg/ml each of aprotinin, leupeptin and pepstatin A) with a tissue homogenizer (PRO Scientific Inc., Oxford, CT) using three pulses of 10 seconds each and then subjected to Dounce homogenizer by 10 strokes.']	(47468, 47849)	['CHEBI_CHMO_EXT:buffer_solution', 'CHEBI:9754', 'CHEBI:26710', 'CHEBI_EXT:EDTA', 'CHEBI:9750', 'CHEBI:9750', 'CHEBI:9750', 'CHEBI:9750', 'CHEBI:18320', 'CHEBI:8102', 'CHEBI:6426', 'CHEBI:7989', 'CHEBI:7989', 'GO:0019835', 'SO_EXT:genotype_or_entity_with_genotype', 'UBERON:0000922', 'UBERON:0000479']
15005800	358	['The homogenates were centrifuged at 10,000 g for 30 minutes at 4°C, supernatants collected, protein concentration determined and used for western blotting.']	(47850, 48005)	['CHEBI_PR_EXT:protein', 'CHEBI_PR_EXT:protein']
15005800	359	['COS1 cells were transfected using Superfect transfection reagent (Qiagen, Valencia, CA) with expression constructs encoding either the full-length Shh or the N-terminal fragment of Shh without post-translational modifications (constructs kindly provided by Dr. Pao-Tien Chuang, Cardiovascular Research Institute, University of California, San Francisco, CA), harvested 3 days after transfection and protein extracts prepared as described above.']	(48006, 48450)	['CHEBI_EXT:33893', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_PR_EXT:protein', 'CL_GO_EXT:cell', 'GO:0009294', 'GO:0009294', 'GO:0010467', 'GO_SO_EXT:post_translational_modification_entity_or_process', 'GO_SO_EXT:post_translational_modification_entity_or_process', 'GO_SO_EXT:post_translational_modification_entity_or_process', 'GO_SO_EXT:post_translational_modification_entity_or_process', 'GO:0009294', 'CL_GO_EXT:cell', 'PR_EXT:000021466', 'PR_EXT:000021466', 'PR_EXT:000021466', 'PR_EXT:000021466', 'PR_EXT:000014841', 'CHEBI_PR_EXT:protein', 'SO_EXT:engineered_biological_sequence', 'SO_EXT:sequence_coding_function', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'GO_SO_EXT:post_translational_modification_entity_or_process', 'GO_SO_EXT:post_translational_modification_entity_or_process', 'GO_SO_EXT:post_translational_modification_entity_or_process', 'GO_SO_EXT:post_translational_modification_entity_or_process', 'SO_EXT:engineered_biological_sequence', 'UBERON:0004535']
15005800	360	["Protein concentration was determined using Bio-Rad protein assay kit (BioRad, Hercules, CA) and 20 μg (COS1 cells) and 75 μg (embryos) of lysates separated by 15 % SDS-PAGE, transferred onto nitrocellulose membrane, incubated with primary antibody (Shh-N19, 1:100) for 2 hours, followed by donkey anti-goat HRP second antibody (1:1000) and visualized by chemiluminescent detection according to manufacturer's protocols (Perkin-Elmer Life Sciences, Boston MA)."]	(48451, 48910)	['CHEBI_PR_EXT:protein', 'CHEBI_PR_EXT:protein', 'CHEBI:8984', 'CHEBI:53325', 'CL_GO_EXT:cell', 'GO_EXT:biological_movement_or_translocation_process', 'CL_GO_EXT:cell', 'GO:0042571', 'GO:0042571', 'NCBITaxon:9793', 'CHEBI_PR_EXT:protein', 'CHEBI_PR_EXT:protein', 'PR_EXT:000014841', 'UBERON:0000922']
15005800	361	['Northern blotting\n\nNorthern blotting was performed as previously described [46], using total RNA (20 μg) from P0 mice lungs.']	(48912, 49036)	['CHEBI_SO_EXT:RNA', 'NCBITaxon:10088', 'CHEBI_SO_EXT:RNA', 'UBERON:0002048']
15005800	362	["The cDNA probes for SP-A, SP-B and SP-C were kindly provided by Dr. Jeffery Whitsett (Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio)."]	(49037, 49219)	['CHEBI_SO_EXT:molecular_probe', 'CHEBI_GO_EXT:biological_process_or_quality_or_role', 'CHEBI_GO_EXT:biological_process_or_quality_or_role', 'NCBITaxon_UBERON_EXT:child', 'PR_EXT:000015945', 'PR_EXT:000015945', 'PR_EXT:000015945', 'PR_EXT:000014773', 'PR_EXT:000014773', 'PR_EXT:000014773', 'PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014774', 'SO_EXT:cDNA', 'CHEBI_SO_EXT:molecular_probe', 'UBERON:0002048', 'NCBITaxon_UBERON_EXT:child']
15005800	363	["A cDNA probe for SP-D was amplified by RT-PCR, using murine SP-D cDNA specific primers (sense 5'-TGCCTGGTCGTGATGGACG-3', and antisense 5'-AGCACTGTCTGGAAGCCCGC-3') and confirmed by sequencing."]	(49220, 49411)	['CHEBI_SO_EXT:molecular_probe', 'GO_EXT:reverse_transcription_or_reverse_transcriptase', 'GO_EXT:reverse_transcription_or_reverse_transcriptase', 'NCBITaxon:39107', 'PR_EXT:000014775', 'PR_EXT:000014775', 'PR_EXT:000014775', 'PR_EXT:000014775', 'PR_EXT:000014775', 'PR_EXT:000014775', 'SO_EXT:cDNA', 'CHEBI_SO_EXT:molecular_probe', 'SO_EXT:cDNA', 'SO_EXT:0000112', 'SO:0000077']
15005800	364	["Author's contributions\n\nHY designed the experiments."]	(49413, 49465)	[]
15005800	365	['HY, ALP and JLC performed experiments.']	(49466, 49504)	[]
15005800	366	['GST analyzed tissue sterols by GC-MS and JO performed lung morphometric analyses.']	(49506, 49587)	['CHEBI:15889', 'UBERON:0000479', 'UBERON:0002048']
15005800	367	['HY, AW and SBP analyzed the data.']	(49588, 49621)	[]
15005800	368	['HY and SBP prepared the manuscript.']	(49622, 49657)	[]
15005800	369	['All authors read and approved the final manuscript.']	(49658, 49709)	[]
15005800	370	['Acknowledgements\n\nWe are grateful to Jeffery Whitsett for providing cDNA probes for SP-A, SP-B and SP-C and Pao-Tien Chuang for the Shh and Shh-N plasmids.']	(49711, 49866)	['CHEBI_SO_EXT:molecular_probe', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'PR_EXT:000015945', 'PR_EXT:000015945', 'PR_EXT:000015945', 'PR_EXT:000014773', 'PR_EXT:000014773', 'PR_EXT:000014773', 'PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014774', 'PR_EXT:000014841', 'PR_EXT:000014841', 'SO_EXT:cDNA', 'CHEBI_SO_EXT:molecular_probe', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'SO_EXT:0000155']
15005800	371	['This research was supported by a Beginning Grant-in-Aid 0160349U from the American Heart Association, Mid-Atlantic Consortium (HY); NIH PO1 HL52813 and NIH PO1 HD39946 (AW) and NIH HL68660 (SBP).']	(49867, 50062)	['UBERON:0000948']
